GOName,GOID,DiseaseName,DiseaseID,InferenceChemicalQty,InferenceChemicalNames,InferenceGeneQty,InferenceGeneSymbols
2-oxoglutarate metabolic process,GO:0006103,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Hydroxychloroquine,0,
2-oxoglutarate metabolic process,GO:0006103,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
2-oxoglutarate metabolic process,GO:0006103,"Lupus Erythematosus, Systemic",MESH:D008180,1,Hydroxychloroquine,0,
2-oxoglutarate metabolic process,GO:0006103,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
4-hydroxyproline biosynthetic process,GO:0019472,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methylprednisolone,0,
4-hydroxyproline biosynthetic process,GO:0019472,Lupus Nephritis,MESH:D008181,1,Methylprednisolone,0,
4-hydroxyproline metabolic process,GO:0019471,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cyclophosphamide|Methylprednisolone|Particulate Matter,0,
4-hydroxyproline metabolic process,GO:0019471,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Methylprednisolone,0,
4-hydroxyproline metabolic process,GO:0019471,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
5-methylcytosine metabolic process,GO:0019857,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
abscission,GO:0009838,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
acetate metabolic process,GO:0006083,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Hydroxychloroquine,0,
acetate metabolic process,GO:0006083,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
acetate metabolic process,GO:0006083,"Lupus Erythematosus, Systemic",MESH:D008180,2,Amiodarone|Hydroxychloroquine,0,
acetoacetic acid metabolic process,GO:0043438,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
acetylcholine metabolic process,GO:0008291,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
acrosome reaction,GO:0007340,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlorpromazine,0,
actin cytoskeleton organization,GO:0030036,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Silicon Dioxide,0,
actin filament capping,GO:0051693,"Lupus Erythematosus, Systemic",MESH:D008180,1,Isoniazid,0,
actin filament capping,GO:0051693,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
actin filament organization,GO:0007015,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
actin filament polymerization,GO:0030041,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Niclosamide,0,
actin filament reorganization,GO:0090527,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
action potential,GO:0001508,"Lupus Erythematosus, Systemic",MESH:D008180,2,Minocycline|Particulate Matter,0,
action potential initiation,GO:0099610,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Valproic Acid,0,
action potential initiation,GO:0099610,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
action potential initiation,GO:0099610,"Lupus Erythematosus, Systemic",MESH:D008180,3,Carbamazepine|Chloroquine|Valproic Acid,0,
activated T cell proliferation,GO:0050798,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IL4|ITGAM
activated T cell proliferation,GO:0050798,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
activation-induced cell death of T cells,GO:0006924,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
activation-induced cell death of T cells,GO:0006924,Lupus Nephritis,MESH:D008181,0,,1,FAS
activation of cysteine-type endopeptidase activity,GO:0097202,"Lupus Erythematosus, Systemic",MESH:D008180,5,Estradiol|Folic Acid|Homocysteine|Indomethacin|Particulate Matter,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Sertraline,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Lupus Erythematosus, Systemic",MESH:D008180,4,Chloroquine|Diclofenac|Indomethacin|Methotrexate,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Niclosamide,0,
activation of GTPase activity,GO:0090630,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,RASGRP1
activation of immune response,GO:0002253,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
activation of immune response,GO:0002253,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
activation of immune response,GO:0002253,"Lupus Erythematosus, Systemic",MESH:D008180,2,Isoniazid|Rifampin,1,TREX1
activation of immune response,GO:0002253,Lupus Nephritis,MESH:D008181,2,Isoniazid|Rifampin,0,
activation of innate immune response,GO:0002218,Chilblain lupus 1,MESH:C535924,0,,1,STING1
activation of innate immune response,GO:0002218,Lupus Nephritis,MESH:D008181,1,Methimazole,1,MMP2
activation of Janus kinase activity,GO:0042976,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL4
activation of protein kinase A activity,GO:0034199,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
activation of protein kinase activity,GO:0032147,"Lupus Erythematosus, Systemic",MESH:D008180,1,Aspirin,0,
activation of protein kinase activity,GO:0032147,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
activation of protein kinase B activity,GO:0032148,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
activation of protein kinase B activity,GO:0032148,"Lupus Erythematosus, Systemic",MESH:D008180,10,Estradiol|Ethosuximide|Folic Acid|Melatonin|Metoprolol|Particulate Matter|Silicon Dioxide|Sulfasalazine|Tobacco Smoke Pollution|triptolide,0,
activation of protein kinase B activity,GO:0032148,Lupus Nephritis,MESH:D008181,4,Dexamethasone|Lipopolysaccharides|Niclosamide|Protein Kinase Inhibitors,0,
activation of protein kinase C activity,GO:1990051,"Lupus Erythematosus, Systemic",MESH:D008180,1,Vincristine,0,
acute inflammatory response,GO:0002526,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,1,TNFSF4
acute inflammatory response,GO:0002526,Lupus Nephritis,MESH:D008181,3,Cyclophosphamide|Dexamethasone|Lipopolysaccharides,0,
acute inflammatory response,GO:0002526,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
acute inflammatory response to antigenic stimulus,GO:0002438,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
acute-phase response,GO:0006953,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CRP|IL6
adaptive immune response,GO:0002250,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
adaptive immune response,GO:0002250,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,1,TCRA
adaptive immune response,GO:0002250,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
adaptive immune response,GO:0002250,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|tofacitinib,5,CSK|CTLA4|HLA-DQA1|PRDM1|TREX1
adaptive immune response,GO:0002250,Lupus Nephritis,MESH:D008181,0,,1,IFNG
adenosine metabolic process,GO:0046085,"Lupus Erythematosus, Systemic",MESH:D008180,2,Amiodarone|Indomethacin,0,
adenosine to inosine editing,GO:0006382,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
adenylate cyclase-inhibiting dopamine receptor signaling pathway,GO:0007195,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PHRF1
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,P2RY12
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,P2RY12
adherens junction maintenance,GO:0034334,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CSK
adherens junction organization,GO:0034332,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CSK
adipose tissue development,GO:0060612,"Lupus Erythematosus, Systemic",MESH:D008180,6,Amiodarone|Folic Acid|Indomethacin|Melatonin|Methylprednisolone|Particulate Matter,0,
adipose tissue development,GO:0060612,Lupus Nephritis,MESH:D008181,3,Dexamethasone|Heparin|Methylprednisolone,0,
ADP biosynthetic process,GO:0006172,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
ADP catabolic process,GO:0046032,"Lupus Erythematosus, Systemic",MESH:D008180,1,Homocysteine,0,
adult behavior,GO:0030534,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cocaine,0,
adult fat body development,GO:0007505,Lupus Nephritis,MESH:D008181,0,,1,MMP2
adult feeding behavior,GO:0008343,"Lupus Erythematosus, Systemic",MESH:D008180,2,Methylprednisolone|triptolide,0,
adult feeding behavior,GO:0008343,Lupus Nephritis,MESH:D008181,1,Methylprednisolone,0,
adult locomotory behavior,GO:0008344,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
adult locomotory behavior,GO:0008344,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cocaine|Particulate Matter|Valproic Acid,0,
adult walking behavior,GO:0007628,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
aerobic electron transport chain,GO:0019646,"Lupus Erythematosus, Systemic",MESH:D008180,2,Diclofenac|Methotrexate,0,
aerobic respiration,GO:0009060,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
aerobic respiration,GO:0009060,"Lupus Erythematosus, Systemic",MESH:D008180,4,Amiodarone|Particulate Matter|Propylthiouracil|Valproic Acid,1,CAT
aerobic respiration,GO:0009060,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Propylthiouracil,0,
aggressive behavior,GO:0002118,"Lupus Erythematosus, Systemic",MESH:D008180,1,Propylthiouracil,0,
aggressive behavior,GO:0002118,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
alanine metabolic process,GO:0006522,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
alcohol metabolic process,GO:0006066,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
aldosterone biosynthetic process,GO:0032342,Lupus Nephritis,MESH:D008181,1,Rutin,0,
alpha-beta T cell differentiation,GO:0046632,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
alpha-tubulin acetylation,GO:0071929,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
"alternative mRNA splicing, via spliceosome",GO:0000380,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
amacrine cell differentiation,GO:0035881,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IKZF1
amine metabolic process,GO:0009308,"Lupus Erythematosus, Systemic",MESH:D008180,2,Indomethacin|Methotrexate,0,
amino-acid betaine metabolic process,GO:0006577,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
amino acid biosynthetic process,GO:0008652,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Lupus Erythematosus, Systemic",MESH:D008180,5,Folic Acid|Homocysteine|triptolide|Valproic Acid|Vitamin B 12,0,
amino acid biosynthetic process,GO:0008652,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
amino acid metabolic process,GO:0006520,"Lupus Erythematosus, Systemic",MESH:D008180,8,Amiodarone|Homocysteine|Indomethacin|Melatonin|Methotrexate|Particulate Matter|Propylthiouracil|triptolide,0,
amino acid metabolic process,GO:0006520,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
AMP catabolic process,GO:0006196,"Lupus Erythematosus, Systemic",MESH:D008180,1,Homocysteine,0,
AMP metabolic process,GO:0046033,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
amyloid-beta clearance,GO:0097242,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CLU|ITGAM
amyloid-beta clearance,GO:0097242,Lupus Nephritis,MESH:D008181,0,,1,C3
amyloid-beta clearance,GO:0097242,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
amyloid-beta metabolic process,GO:0050435,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
amyloid fibril formation,GO:1990000,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
anagen,GO:0042640,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,1,PTGS2
anagen,GO:0042640,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
anagen,GO:0042640,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
anatomical structure development,GO:0048856,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
anatomical structure development,GO:0048856,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
anatomical structure regression,GO:0060033,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
androgen metabolic process,GO:0008209,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
androgen metabolic process,GO:0008209,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Rifampin,0,
androgen metabolic process,GO:0008209,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Rifampin,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlorpromazine,0,
angiogenesis,GO:0001525,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Quinacrine|Thalidomide,0,
angiogenesis,GO:0001525,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Thalidomide,0,
angiogenesis,GO:0001525,"Lupus Erythematosus, Systemic",MESH:D008180,7,Amiodarone|Chloroquine|Folic Acid|Particulate Matter|Quinacrine|Thalidomide|tofacitinib,1,PTGS2
angiogenesis,GO:0001525,Lupus Nephritis,MESH:D008181,1,Dexamethasone,1,MMP2
angiogenesis,GO:0001525,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
angiogenesis involved in wound healing,GO:0060055,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,ETS1
angiogenesis involved in wound healing,GO:0060055,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
animal organ morphogenesis,GO:0009887,"Lupus Erythematosus, Systemic",MESH:D008180,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
animal organ regeneration,GO:0031100,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,ANXA3
anoikis,GO:0043276,"Lupus Erythematosus, Systemic",MESH:D008180,1,Celecoxib,0,
antibiotic metabolic process,GO:0016999,"Lupus Erythematosus, Systemic",MESH:D008180,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
antibody-dependent cellular cytotoxicity,GO:0001788,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2A
antibody-dependent cellular cytotoxicity,GO:0001788,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,FCGR3A
antigen processing and presentation,GO:0019882,Lupus Nephritis,MESH:D008181,0,,1,IFNG
antigen processing and presentation of endogenous peptide antigen via MHC class II,GO:0002491,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,HLA-DRB1
antigen processing and presentation of exogenous antigen,GO:0019884,Lupus Nephritis,MESH:D008181,1,Methimazole,0,
antigen processing and presentation of exogenous peptide antigen via MHC class I,GO:0042590,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2A
antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0019886,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,FCGR2B|HLA-DRB1
antiviral innate immune response,GO:0140374,Chilblain lupus 1,MESH:C535924,0,,1,STING1
antiviral innate immune response,GO:0140374,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IFIH1
aorta development,GO:0035904,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
apical dendrite arborization,GO:0150023,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
apical dendrite arborization,GO:0150023,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Methotrexate,0,
apical dendrite arborization,GO:0150023,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
apical dendrite arborization,GO:0150023,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
apical dendrite morphogenesis,GO:0150021,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
apical protein localization,GO:0045176,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
apoptotic cell clearance,GO:0043277,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
apoptotic cell clearance,GO:0043277,"Lupus Erythematosus, Systemic",MESH:D008180,3,Aspirin|Phenylbutazone|pristane,1,TREX1
apoptotic cell clearance,GO:0043277,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
apoptotic chromosome condensation,GO:0030263,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Fluorouracil|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
apoptotic chromosome condensation,GO:0030263,"Lupus Erythematosus, Systemic",MESH:D008180,9,Amiodarone|Chloroquine|Cyclophosphamide|Melatonin|Methotrexate|Particulate Matter|Tacrolimus|Valproic Acid|Vincristine,0,
apoptotic chromosome condensation,GO:0030263,Lupus Nephritis,MESH:D008181,4,Cyclophosphamide|Lipopolysaccharides|Niclosamide|Tacrolimus,0,
apoptotic chromosome condensation,GO:0030263,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
apoptotic DNA fragmentation,GO:0006309,"Lupus Erythematosus, Cutaneous",MESH:D008178,5,Chloroquine|Fluorouracil|Prednisolone|Thalidomide|Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Thalidomide,0,
apoptotic DNA fragmentation,GO:0006309,"Lupus Erythematosus, Systemic",MESH:D008180,24,Amiodarone|Aspirin|Celecoxib|Chloroquine|Cocaine|Cyclophosphamide|Diclofenac|Estradiol|Glucocorticoids|Homocysteine|Ibuprofen|Indomethacin|Isoniazid|Melatonin|Methylprednisolone|Minocycline|Particulate Matter|Prednisolone|Sulfasalazine|Tacrolimus|Thalidomide|triptolide|Valproic Acid|Vincristine,1,DNASE1L3
apoptotic DNA fragmentation,GO:0006309,Lupus Nephritis,MESH:D008181,9,Cyclophosphamide|Dexamethasone|Heparin|Isoniazid|Lipopolysaccharides|Methylprednisolone|Pentoxifylline|Prednisolone|Tacrolimus,0,
apoptotic DNA fragmentation,GO:0006309,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
apoptotic DNA fragmentation,GO:0006309,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
apoptotic nuclear changes,GO:0030262,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
apoptotic nuclear changes,GO:0030262,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
apoptotic nuclear changes,GO:0030262,"Lupus Erythematosus, Systemic",MESH:D008180,4,Chloroquine|Melatonin|Silicon Dioxide|Tobacco Smoke Pollution,0,
apoptotic process,GO:0006915,"Lupus Erythematosus, Cutaneous",MESH:D008178,11,Chloroquine|Fluorouracil|Hydroxychloroquine|Nitrendipine|pimecrolimus|Prednisolone|Quinacrine|Rifampin|Sertraline|Thalidomide|Valproic Acid,0,
apoptotic process,GO:0006915,"Lupus Erythematosus, Discoid",MESH:D008179,3,Chloroquine|Hydroxychloroquine|Thalidomide,0,
apoptotic process,GO:0006915,"Lupus Erythematosus, Systemic",MESH:D008180,43,Amiodarone|Aspirin|Celecoxib|Chlorambucil|Chloroquine|chloroquine diphosphate|Chlorpromazine|Cocaine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Glucocorticoids|Homocysteine|Hydralazine|Hydroxychloroquine|Ibuprofen|Indomethacin|Isoniazid|Melatonin|Methotrexate|Methylprednisolone|Metoprolol|Minocycline|Mycophenolic Acid|Particulate Matter|Penicillamine|Prednisolone|Propylthiouracil|Quinacrine|Quinidine|Ranitidine|Rifampin|Silicon Dioxide|Sulfasalazine|Tacrolimus|Thalidomide|Tobacco Smoke Pollution|tofacitinib|triptolide|Valproic Acid|Vincristine|Vitamin B 12,3,DNASE1|FAS|TNFAIP3
apoptotic process,GO:0006915,Lupus Nephritis,MESH:D008181,19,arsenic disulfide|Chlorambucil|Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Heparin|Isoniazid|Lipopolysaccharides|Methimazole|Methylprednisolone|Mycophenolic Acid|Niclosamide|Pentoxifylline|Prednisolone|Propylthiouracil|Quinidine|Rifampin|Rutin|Tacrolimus,3,FAS|IFNG|MMP9
apoptotic process,GO:0006915,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
apoptotic process,GO:0006915,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
apoptotic signaling pathway,GO:0097190,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
apoptotic signaling pathway,GO:0097190,Lupus Nephritis,MESH:D008181,0,,1,FAS
arginine catabolic process,GO:0006527,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
arginine metabolic process,GO:0006525,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
artery morphogenesis,GO:0048844,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
artery smooth muscle contraction,GO:0014824,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Tobacco Smoke Pollution,0,
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,GO:0001984,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
articular cartilage development,GO:0061975,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
asparagine metabolic process,GO:0006528,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
aspartate biosynthetic process,GO:0006532,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methylprednisolone,0,
aspartate biosynthetic process,GO:0006532,Lupus Nephritis,MESH:D008181,1,Methylprednisolone,0,
aspartate catabolic process,GO:0006533,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
aspartate catabolic process,GO:0006533,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
aspartate catabolic process,GO:0006533,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
aspartate metabolic process,GO:0006531,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Hydroxychloroquine,0,
aspartate metabolic process,GO:0006531,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
aspartate metabolic process,GO:0006531,"Lupus Erythematosus, Systemic",MESH:D008180,2,Hydroxychloroquine|Particulate Matter,0,
aspartate metabolic process,GO:0006531,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
associative learning,GO:0008306,"Lupus Erythematosus, Systemic",MESH:D008180,1,Aspirin,0,
astrocyte activation,GO:0048143,"Lupus Erythematosus, Systemic",MESH:D008180,2,Ibuprofen|Particulate Matter,1,C1QA
astrocyte activation,GO:0048143,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,1,IFNG
astrocyte cell migration,GO:0043615,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
asymmetric neuroblast division,GO:0055059,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CLU
ATP biosynthetic process,GO:0006754,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Fluorouracil|Rifampin|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Lupus Erythematosus, Systemic",MESH:D008180,9,Chlorpromazine|Isoniazid|Melatonin|Particulate Matter|Rifampin|Silicon Dioxide|Tobacco Smoke Pollution|triptolide|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,Lupus Nephritis,MESH:D008181,5,Diethylstilbestrol|Isoniazid|Lipopolysaccharides|Niclosamide|Rifampin,0,
ATP generation from ADP,GO:0006757,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Niclosamide,0,
ATP metabolic process,GO:0046034,"Lupus Erythematosus, Cutaneous",MESH:D008178,7,Chloroquine|Fluorouracil|Quinacrine|Rifampin|Sertraline|Thalidomide|Valproic Acid,0,
ATP metabolic process,GO:0046034,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Thalidomide,0,
ATP metabolic process,GO:0046034,"Lupus Erythematosus, Systemic",MESH:D008180,19,Amiodarone|Celecoxib|Chloroquine|Chlorpromazine|Diclofenac|Estradiol|Homocysteine|Indomethacin|Melatonin|Methotrexate|Particulate Matter|Propylthiouracil|Quinacrine|Quinidine|Rifampin|Silicon Dioxide|Thalidomide|triptolide|Valproic Acid,0,
ATP metabolic process,GO:0046034,Lupus Nephritis,MESH:D008181,8,arsenic disulfide|Dexamethasone|Diethylstilbestrol|Lipopolysaccharides|Niclosamide|Propylthiouracil|Quinidine|Rifampin,0,
ATP metabolic process,GO:0046034,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
atrial cardiac muscle tissue development,GO:0003228,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
atrial cardiac muscle tissue development,GO:0003228,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
attachment of spindle microtubules to kinetochore,GO:0008608,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
autophagic cell death,GO:0048102,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
autophagic cell death,GO:0048102,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
autophagic cell death,GO:0048102,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
autophagic cell death,GO:0048102,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
autophagosome assembly,GO:0000045,Chilblain lupus 1,MESH:C535924,0,,1,STING1
autophagosome assembly,GO:0000045,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Rifampin,0,
autophagosome assembly,GO:0000045,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
autophagosome assembly,GO:0000045,"Lupus Erythematosus, Systemic",MESH:D008180,7,Amiodarone|Chloroquine|chloroquine diphosphate|Melatonin|Rifampin|Silicon Dioxide|triptolide,0,
autophagosome assembly,GO:0000045,Lupus Nephritis,MESH:D008181,4,Dexamethasone|Lipopolysaccharides|Niclosamide|Rifampin,0,
autophagosome-lysosome fusion,GO:0061909,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
autophagosome-lysosome fusion,GO:0061909,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
autophagosome-lysosome fusion,GO:0061909,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chloroquine|chloroquine diphosphate|Silicon Dioxide,0,
autophagosome membrane disassembly,GO:0030399,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
autophagosome membrane disassembly,GO:0030399,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
autophagosome membrane disassembly,GO:0030399,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Silicon Dioxide,0,
autophagosome organization,GO:1905037,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
autophagosome organization,GO:1905037,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
autophagosome organization,GO:1905037,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
autophagosome organization,GO:1905037,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
autophagy,GO:0006914,"Lupus Erythematosus, Cutaneous",MESH:D008178,6,Chloroquine|Fluorouracil|Hydroxychloroquine|Rifampin|Sertraline|Thalidomide,0,
autophagy,GO:0006914,"Lupus Erythematosus, Discoid",MESH:D008179,3,Chloroquine|Hydroxychloroquine|Thalidomide,0,
autophagy,GO:0006914,"Lupus Erythematosus, Systemic",MESH:D008180,13,Celecoxib|Chloroquine|chloroquine diphosphate|Cocaine|Hydroxychloroquine|Indomethacin|Melatonin|Minocycline|Particulate Matter|Rifampin|Silicon Dioxide|Thalidomide|triptolide,3,CLEC16A|IL4|PTPN22
autophagy,GO:0006914,Lupus Nephritis,MESH:D008181,6,Dexamethasone|Diethylstilbestrol|Lipopolysaccharides|Niclosamide|Pentoxifylline|Rifampin,0,
autophagy,GO:0006914,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
axonal transport,GO:0098930,"Lupus Erythematosus, Systemic",MESH:D008180,1,Vincristine,0,
axon arborization,GO:0140060,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
axon extension,GO:0048675,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
axonogenesis,GO:0007409,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
B-1 B cell homeostasis,GO:0001922,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNFAIP3
basal dendrite arborization,GO:0150020,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
basal dendrite arborization,GO:0150020,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Methotrexate,0,
basal dendrite arborization,GO:0150020,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
basal dendrite arborization,GO:0150020,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
base-excision repair,GO:0006284,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
"base-excision repair, AP site formation",GO:0006285,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
basement membrane disassembly,GO:0034769,Lupus Nephritis,MESH:D008181,0,,1,MMP2
basement membrane organization,GO:0071711,Lupus Nephritis,MESH:D008181,0,,1,MMP2
B cell activation,GO:0042113,"Lupus Erythematosus, Systemic",MESH:D008180,0,,4,BANK1|CR2|IL4|RASGRP1
B cell activation,GO:0042113,Lupus Nephritis,MESH:D008181,0,,1,C3
B cell apoptotic process,GO:0001783,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL21
B cell costimulation,GO:0031296,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL4
B cell differentiation,GO:0030183,"Lupus Erythematosus, Systemic",MESH:D008180,0,,5,CD40LG|CR2|IKZF1|IL10|IL4
B cell homeostasis,GO:0001782,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
B cell homeostasis,GO:0001782,Lupus Nephritis,MESH:D008181,2,Niclosamide|resiquimod,0,
B cell mediated immunity,GO:0019724,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
B cell mediated immunity,GO:0019724,Lupus Nephritis,MESH:D008181,0,,1,FAS
B cell proliferation,GO:0042100,"Lupus Erythematosus, Systemic",MESH:D008180,0,,7,CD40LG|CFB|CR2|FCGR2B|IL10|IL4|RASGRP1
B cell proliferation,GO:0042100,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
B cell receptor signaling pathway,GO:0050853,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,BANK1|BLK|CTLA4
behavior,GO:0007610,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Tobacco Smoke Pollution,0,
behavior,GO:0007610,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
behavioral fear response,GO:0001662,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cocaine|Folic Acid,0,
behavioral response to acetic acid induced pain,GO:0061367,"Lupus Erythematosus, Systemic",MESH:D008180,3,Diclofenac|Indomethacin|Vincristine,0,
behavioral response to chemical pain,GO:0061366,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Indomethacin,0,
behavioral response to chemical pain,GO:0061366,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
behavioral response to chemical pain,GO:0061366,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
behavioral response to cocaine,GO:0048148,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cocaine,0,
behavioral response to nicotine,GO:0035095,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cocaine,0,
behavioral response to pain,GO:0048266,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
behavioral response to pain,GO:0048266,"Lupus Erythematosus, Systemic",MESH:D008180,7,Diclofenac|Ibuprofen|Indomethacin|Methotrexate|Minocycline|Valproic Acid|Vincristine,0,
behavioral response to pain,GO:0048266,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Pentoxifylline,0,
benzoate transport,GO:0042919,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
beta-alanine metabolic process,GO:0019482,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
bile acid and bile salt transport,GO:0015721,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlorpromazine,0,
bile acid biosynthetic process,GO:0006699,"Lupus Erythematosus, Systemic",MESH:D008180,2,Ibuprofen|Melatonin,0,
bile acid biosynthetic process,GO:0006699,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
bile acid metabolic process,GO:0008206,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
bile acid metabolic process,GO:0008206,"Lupus Erythematosus, Systemic",MESH:D008180,5,Diclofenac|Estradiol|Isoniazid|Rifampin|triptolide,0,
bile acid metabolic process,GO:0008206,Lupus Nephritis,MESH:D008181,3,Isoniazid|Lipopolysaccharides|Rifampin,0,
bile acid secretion,GO:0032782,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
bile acid secretion,GO:0032782,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chlorpromazine|Rifampin,0,
bile acid secretion,GO:0032782,Lupus Nephritis,MESH:D008181,1,Rifampin,0,
bilirubin transport,GO:0015723,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Prednisolone|Rifampin,0,
bilirubin transport,GO:0015723,"Lupus Erythematosus, Systemic",MESH:D008180,6,Folic Acid|Homocysteine|Isoniazid|Methotrexate|Prednisolone|Rifampin,0,
bilirubin transport,GO:0015723,Lupus Nephritis,MESH:D008181,3,Isoniazid|Prednisolone|Rifampin,0,
binding of sperm to zona pellucida,GO:0007339,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
biological_process,GO:0008150,"Lupus Erythematosus, Systemic",MESH:D008180,0,,11,BANK1|BLK|BLTP3A|CD226|CLEC16A|IL21R|PCNX3|PXK|RASGRP3|STAT4|TCF7
biological_process,GO:0008150,Lupus Nephritis,MESH:D008181,0,,1,JAK1
biological process involved in symbiotic interaction,GO:0044403,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
biosynthetic process of antibacterial peptides active against Gram-positive bacteria,GO:0002815,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
blastocyst development,GO:0001824,"Lupus Erythematosus, Systemic",MESH:D008180,1,Isoniazid,0,
blastocyst development,GO:0001824,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
blastocyst formation,GO:0001825,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cyclophosphamide|Estradiol|Melatonin,0,
blastocyst formation,GO:0001825,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
blastocyst formation,GO:0001825,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
blood circulation,GO:0008015,"Lupus Erythematosus, Systemic",MESH:D008180,2,Diclofenac|Particulate Matter,0,
blood circulation,GO:0008015,Lupus Nephritis,MESH:D008181,0,,2,SERPING1|STAT1
blood coagulation,GO:0007596,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
blood coagulation,GO:0007596,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Rifampin,1,P2RY12
blood coagulation,GO:0007596,Lupus Nephritis,MESH:D008181,2,Heparin|Rifampin,1,SERPING1
"blood coagulation, fibrin clot formation",GO:0072378,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
"blood coagulation, fibrin clot formation",GO:0072378,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
blood vessel development,GO:0001568,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
blood vessel development,GO:0001568,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,2,TNFSF4|TREX1
blood vessel diameter maintenance,GO:0097746,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Tobacco Smoke Pollution,0,
blood vessel endothelial cell differentiation,GO:0060837,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,ETS1
blood vessel maturation,GO:0001955,Lupus Nephritis,MESH:D008181,0,,1,MMP2
blood vessel morphogenesis,GO:0048514,"Lupus Erythematosus, Systemic",MESH:D008180,1,Penicillamine,1,ETS1
blood vessel remodeling,GO:0001974,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
blood vessel remodeling,GO:0001974,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
bone development,GO:0060348,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Prednisolone,0,
bone development,GO:0060348,"Lupus Erythematosus, Systemic",MESH:D008180,3,Metoprolol|Particulate Matter|Prednisolone,1,CR2
bone development,GO:0060348,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Prednisolone,0,
bone growth,GO:0098868,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
bone growth,GO:0098868,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
bone mineralization,GO:0030282,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Hydroxychloroquine|Prednisolone|Prednisone,0,
bone mineralization,GO:0030282,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
bone mineralization,GO:0030282,"Lupus Erythematosus, Systemic",MESH:D008180,4,Estradiol|Hydroxychloroquine|Prednisolone|Prednisone,1,PTGS2
bone mineralization,GO:0030282,Lupus Nephritis,MESH:D008181,5,Dexamethasone|Lipopolysaccharides|Prednisolone|Prednisone|Rutin,0,
bone mineralization,GO:0030282,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Prednisone,0,
bone remodeling,GO:0046849,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
bone resorption,GO:0045453,"Lupus Erythematosus, Systemic",MESH:D008180,2,Methylprednisolone|tofacitinib,0,
bone resorption,GO:0045453,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Methylprednisolone,0,
bone trabecula formation,GO:0060346,Lupus Nephritis,MESH:D008181,0,,1,MMP2
brain development,GO:0007420,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
brain development,GO:0007420,"Lupus Erythematosus, Systemic",MESH:D008180,4,Folic Acid|Particulate Matter|Propylthiouracil|Tobacco Smoke Pollution,0,
brain development,GO:0007420,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
branching involved in labyrinthine layer morphogenesis,GO:0060670,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL10
branching involved in salivary gland morphogenesis,GO:0060445,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
brown fat cell differentiation,GO:0050873,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,1,PTGS2
brown fat cell differentiation,GO:0050873,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
brown fat cell proliferation,GO:0070342,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
C21-steroid hormone metabolic process,GO:0008207,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
C-5 methylation of cytosine,GO:0090116,"Lupus Erythematosus, Systemic",MESH:D008180,3,Estradiol|Particulate Matter|Tobacco Smoke Pollution,0,
calcium import into the mitochondrion,GO:0036444,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Lupus Erythematosus, Discoid",MESH:D008179,1,Azathioprine,0,
calcium ion homeostasis,GO:0055074,"Lupus Erythematosus, Systemic",MESH:D008180,10,Amiodarone|Azathioprine|Chlorpromazine|Estradiol|Isoniazid|Methotrexate|Methylprednisolone|Tobacco Smoke Pollution|triptolide|Valproic Acid,0,
calcium ion homeostasis,GO:0055074,Lupus Nephritis,MESH:D008181,5,Azathioprine|Dexamethasone|Heparin|Isoniazid|Methylprednisolone,0,
calcium ion homeostasis,GO:0055074,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Azathioprine,0,
calcium ion import,GO:0070509,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
calcium ion transmembrane transport,GO:0070588,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,P2RY12
calcium-mediated signaling,GO:0019722,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Fluorouracil|Thalidomide,0,
calcium-mediated signaling,GO:0019722,"Lupus Erythematosus, Discoid",MESH:D008179,1,Thalidomide,0,
calcium-mediated signaling,GO:0019722,"Lupus Erythematosus, Systemic",MESH:D008180,10,Celecoxib|Chlorambucil|Diclofenac|Homocysteine|Melatonin|Methylprednisolone|Particulate Matter|Quinidine|Thalidomide|Vitamin B 12,1,P2RY12
calcium-mediated signaling,GO:0019722,Lupus Nephritis,MESH:D008181,4,Chlorambucil|Dexamethasone|Methylprednisolone|Quinidine,0,
calcium-mediated signaling,GO:0019722,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,FCGR3A
calcium-mediated signaling,GO:0019722,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
calcium-mediated signaling using intracellular calcium source,GO:0035584,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
calcium-mediated signaling using intracellular calcium source,GO:0035584,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
calcium-mediated signaling using intracellular calcium source,GO:0035584,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
cAMP biosynthetic process,GO:0006171,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
cAMP biosynthetic process,GO:0006171,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cAMP biosynthetic process,GO:0006171,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chloroquine|Estradiol|Particulate Matter,0,
cAMP biosynthetic process,GO:0006171,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Protein Kinase Inhibitors,0,
cAMP metabolic process,GO:0046058,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Particulate Matter,0,
cAMP metabolic process,GO:0046058,Lupus Nephritis,MESH:D008181,3,Cyclophosphamide|Methimazole|Pentoxifylline,0,
cAMP metabolic process,GO:0046058,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cAMP transport,GO:0070730,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
canonical Wnt signaling pathway,GO:0060070,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
canonical Wnt signaling pathway,GO:0060070,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,GO:0044338,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
canonical Wnt signaling pathway involved in negative regulation of apoptotic process,GO:0044336,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
carbohydrate metabolic process,GO:0005975,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
carbohydrate metabolic process,GO:0005975,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
carboxylic acid metabolic process,GO:0019752,"Lupus Erythematosus, Systemic",MESH:D008180,2,Indomethacin|Methotrexate,0,
cardiac muscle cell contraction,GO:0086003,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
cardiac muscle cell contraction,GO:0086003,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cardiac muscle cell contraction,GO:0086003,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Quinidine,0,
cardiac muscle cell contraction,GO:0086003,Lupus Nephritis,MESH:D008181,1,Quinidine,0,
cardiac muscle cell development,GO:0055013,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
cardiac muscle cell differentiation,GO:0055007,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Fluorouracil|Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
cardiac muscle contraction,GO:0060048,"Lupus Erythematosus, Systemic",MESH:D008180,3,Amiodarone|Particulate Matter|Quinidine,0,
cardiac muscle contraction,GO:0060048,Lupus Nephritis,MESH:D008181,1,Quinidine,0,
cardiac muscle hypertrophy,GO:0003300,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cardiac septum development,GO:0003279,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
cardioblast migration to the midline involved in heart rudiment formation,GO:0003319,Lupus Nephritis,MESH:D008181,0,,1,MMP2
carnitine biosynthetic process,GO:0045329,Lupus Nephritis,MESH:D008181,1,Rutin,0,
carnitine metabolic process,GO:0009437,"Lupus Erythematosus, Systemic",MESH:D008180,3,Amiodarone|Indomethacin|triptolide,0,
cartilage development,GO:0051216,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
cartilage development,GO:0051216,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,1,CR2
cartilage development,GO:0051216,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
catecholamine secretion,GO:0050432,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Cinnarizine,0,
CD40 signaling pathway,GO:0023035,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CD40LG
"CD4-positive, alpha-beta T cell activation",GO:0035710,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
"CD4-positive, alpha-beta T cell costimulation",GO:0035783,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNFSF4
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,"Lupus Erythematosus, Systemic",MESH:D008180,1,Carbamazepine,0,
CD86 biosynthetic process,GO:0035781,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
CD86 biosynthetic process,GO:0035781,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
"CD8-positive, alpha-beta T cell activation",GO:0036037,"Lupus Erythematosus, Systemic",MESH:D008180,1,tofacitinib,0,
"CD8-positive, alpha-beta T cell differentiation involved in immune response",GO:0002302,Lupus Nephritis,MESH:D008181,0,,1,IFNG
cell-abiotic substrate adhesion,GO:0036164,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
cell-abiotic substrate adhesion,GO:0036164,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cell-abiotic substrate adhesion,GO:0036164,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
cell activation,GO:0001775,"Lupus Erythematosus, Systemic",MESH:D008180,1,Minocycline,0,
cell adhesion,GO:0007155,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Folic Acid,3,CD226|ITGAM|SIGLEC6
cell adhesion,GO:0007155,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
cell adhesion mediated by integrin,GO:0033627,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,ITGAM
cell adhesion mediated by integrin,GO:0033627,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
cell aggregation,GO:0098743,"Lupus Erythematosus, Systemic",MESH:D008180,7,Celecoxib|Chlorpromazine|Diclofenac|Ibuprofen|Indomethacin|Mefenamic Acid|Silicon Dioxide,0,
cell aggregation,GO:0098743,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Niclosamide,0,
cell-cell adhesion,GO:0098609,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
cell-cell adhesion,GO:0098609,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cell-cell adhesion,GO:0098609,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Silicon Dioxide,1,ITGAM
cell-cell adhesion,GO:0098609,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
cell-cell adhesion,GO:0098609,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
cell-cell adhesion in response to extracellular stimulus,GO:0140039,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098742,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,ITGAM
cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098742,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
cell-cell fusion,GO:0140253,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
cell-cell junction organization,GO:0045216,Lupus Nephritis,MESH:D008181,0,,1,MMP2
cell-cell signaling,GO:0007267,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,C1QA|SIGLEC6
cell-cell signaling via exosome,GO:0099156,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cell chemotaxis,GO:0060326,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Rifampin|Valproic Acid,0,
cell chemotaxis,GO:0060326,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cell chemotaxis,GO:0060326,"Lupus Erythematosus, Systemic",MESH:D008180,14,Amiodarone|Aspirin|Chloroquine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Ibuprofen|Indomethacin|Melatonin|Mycophenolic Acid|Particulate Matter|Rifampin|Valproic Acid,0,
cell chemotaxis,GO:0060326,Lupus Nephritis,MESH:D008181,8,Cyclophosphamide|Dexamethasone|Heparin|Lipopolysaccharides|Mycophenolic Acid|Niclosamide|Pentoxifylline|Rifampin,0,
cell chemotaxis,GO:0060326,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell communication,GO:0007154,"Lupus Erythematosus, Systemic",MESH:D008180,1,Triglycerides,0,
cell cycle,GO:0007049,"Lupus Erythematosus, Cutaneous",MESH:D008178,6,Chloroquine|Fluorouracil|Prednisolone|Rifampin|Thalidomide|Valproic Acid,0,
cell cycle,GO:0007049,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Thalidomide,0,
cell cycle,GO:0007049,"Lupus Erythematosus, Systemic",MESH:D008180,22,Aspirin|Celecoxib|Chloroquine|Cocaine|Cyclophosphamide|Estradiol|Homocysteine|Ibuprofen|Indomethacin|Melatonin|Methotrexate|Mycophenolic Acid|Penicillamine|Prednisolone|Quinidine|Rifampin|Tacrolimus|Thalidomide|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vincristine,0,
cell cycle,GO:0007049,Lupus Nephritis,MESH:D008181,11,Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Heparin|Methimazole|Mycophenolic Acid|Pentoxifylline|Prednisolone|Quinidine|Rifampin|Tacrolimus,0,
cell cycle,GO:0007049,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell cycle,GO:0007049,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
cell cycle G1/S phase transition,GO:0044843,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
cell cycle G2/M phase transition,GO:0044839,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
cell death,GO:0008219,"Lupus Erythematosus, Cutaneous",MESH:D008178,7,Chloroquine|Dapsone|Fluorouracil|Quinacrine|Rifampin|Thalidomide|Valproic Acid,0,
cell death,GO:0008219,"Lupus Erythematosus, Discoid",MESH:D008179,3,Azathioprine|Chloroquine|Thalidomide,0,
cell death,GO:0008219,"Lupus Erythematosus, Systemic",MESH:D008180,40,Amiodarone|Aspirin|Azathioprine|Carbamazepine|Celecoxib|Chlorambucil|Chloroquine|Chlorpromazine|Cocaine|Diclofenac|Estradiol|Ethosuximide|Folic Acid|Glucocorticoids|Griseofulvin|Homocysteine|Hydralazine|Ibuprofen|Indomethacin|Isoniazid|Mefenamic Acid|Melatonin|Methotrexate|Methyldopa|Methylprednisolone|Metoprolol|Minocycline|Mycophenolic Acid|Particulate Matter|Penicillamine|Quinacrine|Quinidine|Rifampin|Silicon Dioxide|Tacrolimus|Thalidomide|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vincristine,0,
cell death,GO:0008219,Lupus Nephritis,MESH:D008181,15,Azathioprine|Chlorambucil|Dexamethasone|Heparin|Isoniazid|Lipopolysaccharides|Methimazole|Methylprednisolone|Mycophenolic Acid|Niclosamide|Pentoxifylline|Quinidine|Rifampin|Rutin|Tacrolimus,0,
cell death,GO:0008219,"Panniculitis, Lupus Erythematosus",MESH:D015435,2,Azathioprine|Thalidomide,0,
cell differentiation,GO:0030154,"Lupus Erythematosus, Cutaneous",MESH:D008178,4,Chloroquine|Fluorouracil|Thalidomide|Valproic Acid,0,
cell differentiation,GO:0030154,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Thalidomide,0,
cell differentiation,GO:0030154,"Lupus Erythematosus, Systemic",MESH:D008180,15,Aspirin|Chloroquine|Cocaine|Cyclophosphamide|Diclofenac|Estradiol|Glucocorticoids|Homocysteine|Indomethacin|Melatonin|Quinidine|Tacrolimus|Thalidomide|Tobacco Smoke Pollution|Valproic Acid,4,BLK|ETS1|IL6|RASGRP1
cell differentiation,GO:0030154,Lupus Nephritis,MESH:D008181,8,Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Heparin|Lipopolysaccharides|Pentoxifylline|Quinidine|Tacrolimus,1,JAK1
cell differentiation,GO:0030154,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell differentiation,GO:0030154,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
cell division,GO:0051301,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Vincristine,0,
cell division,GO:0051301,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
cell division,GO:0051301,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell fate commitment,GO:0045165,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
cell growth,GO:0016049,"Lupus Erythematosus, Cutaneous",MESH:D008178,4,Chloroquine|Fluorouracil|Thalidomide|Valproic Acid,0,
cell growth,GO:0016049,"Lupus Erythematosus, Discoid",MESH:D008179,3,Azathioprine|Chloroquine|Thalidomide,0,
cell growth,GO:0016049,"Lupus Erythematosus, Systemic",MESH:D008180,23,Amiodarone|Azathioprine|Carbamazepine|Chloroquine|chloroquine diphosphate|Chlorpromazine|Cocaine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Homocysteine|Isoniazid|Melatonin|Methotrexate|Metoprolol|Particulate Matter|Silicon Dioxide|Thalidomide|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vincristine,0,
cell growth,GO:0016049,Lupus Nephritis,MESH:D008181,8,arsenic disulfide|Azathioprine|Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Isoniazid|Lipopolysaccharides|Niclosamide,0,
cell growth,GO:0016049,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell growth,GO:0016049,"Panniculitis, Lupus Erythematosus",MESH:D015435,2,Azathioprine|Thalidomide,0,
cell-matrix adhesion,GO:0007160,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,ITGAM
cell-matrix adhesion,GO:0007160,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
cell maturation,GO:0048469,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL21
cell maturation,GO:0048469,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cell migration,GO:0016477,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Fluorouracil|Valproic Acid,0,
cell migration,GO:0016477,"Lupus Erythematosus, Systemic",MESH:D008180,12,Carbamazepine|Celecoxib|Chlorambucil|Cyclophosphamide|Estradiol|Folic Acid|Indomethacin|Isoniazid|Particulate Matter|Tobacco Smoke Pollution|triptolide|Valproic Acid,3,CSK|IL12B|TNFAIP3
cell migration,GO:0016477,Lupus Nephritis,MESH:D008181,7,Chlorambucil|Cyclophosphamide|Dexamethasone|Isoniazid|Lipopolysaccharides|Niclosamide|Rutin,2,MMP2|MMP9
cell migration,GO:0016477,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell morphogenesis,GO:0000902,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Melatonin,1,CLU
cell morphogenesis,GO:0000902,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
cell morphogenesis,GO:0000902,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell motility,GO:0048870,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,1,ETS1
cell population proliferation,GO:0008283,"Lupus Erythematosus, Cutaneous",MESH:D008178,11,Chloroquine|Fluorouracil|Hydroxychloroquine|Nitrendipine|pimecrolimus|Prednisolone|Quinacrine|Rifampin|Sertraline|Thalidomide|Valproic Acid,0,
cell population proliferation,GO:0008283,"Lupus Erythematosus, Discoid",MESH:D008179,4,Adrenal Cortex Hormones|Chloroquine|Hydroxychloroquine|Thalidomide,0,
cell population proliferation,GO:0008283,"Lupus Erythematosus, Systemic",MESH:D008180,42,Adrenal Cortex Hormones|Amiodarone|Aspirin|Celecoxib|Chlordecone|Chloroquine|Chlorpromazine|Cocaine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Glucocorticoids|Griseofulvin|Homocysteine|Hydralazine|Hydroxychloroquine|Ibuprofen|Indomethacin|Melatonin|Methotrexate|Minocycline|Mycophenolic Acid|Particulate Matter|Penicillamine|Phenylbutazone|Prednisolone|Propylthiouracil|Quinacrine|Quinidine|Ranitidine|Rifampin|Silicon Dioxide|Sulfasalazine|Tacrolimus|Thalidomide|Tobacco Smoke Pollution|tofacitinib|triptolide|Valproic Acid|Vincristine|Vitamin B 12,2,IL12B|PRL
cell population proliferation,GO:0008283,Lupus Nephritis,MESH:D008181,17,arsenic disulfide|Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Heparin|Lipopolysaccharides|Methimazole|Mycophenolic Acid|Nandrolone|Niclosamide|Pentoxifylline|Prednisolone|Propylthiouracil|Quinidine|Rifampin|Rutin|Tacrolimus,1,STAT1
cell population proliferation,GO:0008283,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell population proliferation,GO:0008283,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
cell projection morphogenesis,GO:0048858,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
cell projection morphogenesis,GO:0048858,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cell projection morphogenesis,GO:0048858,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
cell projection organization,GO:0030030,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,1,P2RY12
cell proliferation in bone marrow,GO:0071838,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
cell proliferation in bone marrow,GO:0071838,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
cell proliferation in bone marrow,GO:0071838,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cell proliferation in forebrain,GO:0021846,"Lupus Erythematosus, Systemic",MESH:D008180,1,Ethosuximide,0,
cell recognition,GO:0008037,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CD226
cell redox homeostasis,GO:0045454,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Fluorouracil|Prednisolone,0,
cell redox homeostasis,GO:0045454,"Lupus Erythematosus, Systemic",MESH:D008180,11,Aspirin|Folic Acid|Melatonin|Methotrexate|Particulate Matter|Prednisolone|Silicon Dioxide|Sulfasalazine|Tobacco Smoke Pollution|triptolide|Vitamin B 12,1,IL6
cell redox homeostasis,GO:0045454,Lupus Nephritis,MESH:D008181,1,Prednisolone,0,
cell surface receptor signaling pathway,GO:0007166,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,FCGR2A|FCGR2B|IL12B
cell surface receptor signaling pathway,GO:0007166,Lupus Nephritis,MESH:D008181,0,,2,FCGR3B|IFNG
cell surface receptor signaling pathway,GO:0007166,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,2,FCGR3A|FCGR3B
cellular aldehyde metabolic process,GO:0006081,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlorpromazine,0,
cellular calcium ion homeostasis,GO:0006874,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Fluorouracil|Valproic Acid,0,
cellular calcium ion homeostasis,GO:0006874,"Lupus Erythematosus, Discoid",MESH:D008179,2,Azathioprine|Chloroquine,0,
cellular calcium ion homeostasis,GO:0006874,"Lupus Erythematosus, Systemic",MESH:D008180,16,Amiodarone|Azathioprine|Chloroquine|chloroquine diphosphate|Chlorpromazine|Diclofenac|Estradiol|Folic Acid|Ibuprofen|Indomethacin|Melatonin|Methotrexate|Particulate Matter|Silicon Dioxide|Sulfadiazine|Valproic Acid,0,
cellular calcium ion homeostasis,GO:0006874,Lupus Nephritis,MESH:D008181,6,Azathioprine|Dexamethasone|Diethylstilbestrol|Heparin|Lipopolysaccharides|Niclosamide,0,
cellular calcium ion homeostasis,GO:0006874,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Azathioprine,0,
cellular component organization,GO:0016043,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
cellular defense response,GO:0006968,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,NCF1
cellular detoxification of hydrogen peroxide,GO:0061692,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CAT
cellular developmental process,GO:0048869,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
cellular extravasation,GO:0045123,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,1,ITGAM
cellular extravasation,GO:0045123,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Dexamethasone,0,
cellular extravasation,GO:0045123,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,1,ITGAM
cellular glucose homeostasis,GO:0001678,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Fluorouracil|Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cellular iron ion homeostasis,GO:0006879,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chloroquine|Particulate Matter|Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,Lupus Nephritis,MESH:D008181,1,arsenic disulfide,0,
cellular ketone metabolic process,GO:0042180,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Hydroxychloroquine,0,
cellular ketone metabolic process,GO:0042180,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
cellular ketone metabolic process,GO:0042180,"Lupus Erythematosus, Systemic",MESH:D008180,1,Hydroxychloroquine,0,
cellular lipid catabolic process,GO:0044242,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Methotrexate,0,
cellular lipid catabolic process,GO:0044242,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
cellular lipid metabolic process,GO:0044255,"Lupus Erythematosus, Systemic",MESH:D008180,1,Triglycerides,0,
cellular lipid metabolic process,GO:0044255,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
cellular metabolic process,GO:0044237,"Lupus Erythematosus, Cutaneous",MESH:D008178,6,Chloroquine|Fluorouracil|Hydroxychloroquine|Rifampin|Thalidomide|Valproic Acid,0,
cellular metabolic process,GO:0044237,"Lupus Erythematosus, Discoid",MESH:D008179,4,Azathioprine|Chloroquine|Hydroxychloroquine|Thalidomide,0,
cellular metabolic process,GO:0044237,"Lupus Erythematosus, Systemic",MESH:D008180,36,Amiodarone|Aspirin|Azathioprine|Celecoxib|Chloroquine|chloroquine diphosphate|Chlorpromazine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Homocysteine|Hydroxychloroquine|Ibuprofen|Indomethacin|Isoniazid|Mefenamic Acid|Melatonin|Methotrexate|Metoprolol|Minocycline|Mycophenolic Acid|Nitrofurantoin|Particulate Matter|Penicillamine|Quinidine|Rifampin|Silicon Dioxide|Sulfadiazine|Tacrolimus|Thalidomide|Tobacco Smoke Pollution|tofacitinib|triptolide|Valproic Acid|Vincristine,0,
cellular metabolic process,GO:0044237,Lupus Nephritis,MESH:D008181,14,arsenic disulfide|Azathioprine|Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Isoniazid|Lipopolysaccharides|Mycophenolic Acid|Niclosamide|Pentoxifylline|Quinidine|Rifampin|Rutin|Tacrolimus,0,
cellular metabolic process,GO:0044237,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cellular metabolic process,GO:0044237,"Panniculitis, Lupus Erythematosus",MESH:D015435,2,Azathioprine|Thalidomide,0,
cellular nitric oxide homeostasis,GO:0033484,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Particulate Matter,0,
cellular nitric oxide homeostasis,GO:0033484,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cellular nitrogen compound metabolic process,GO:0034641,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
cellular nitrogen compound metabolic process,GO:0034641,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cellular oxidant detoxification,GO:0098869,"Lupus Erythematosus, Systemic",MESH:D008180,1,Sulfasalazine,2,CAT|PTGS2
cellular oxygen homeostasis,GO:0032364,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cellular respiration,GO:0045333,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
cellular respiration,GO:0045333,"Lupus Erythematosus, Systemic",MESH:D008180,7,Estradiol|Folic Acid|Melatonin|Minocycline|Particulate Matter|triptolide|Valproic Acid,0,
cellular respiration,GO:0045333,Lupus Nephritis,MESH:D008181,4,Dexamethasone|Diethylstilbestrol|Lipopolysaccharides|Pentoxifylline,0,
cellular response to amino acid starvation,GO:0034198,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
cellular response to amino acid starvation,GO:0034198,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to amino acid stimulus,GO:0071230,Lupus Nephritis,MESH:D008181,0,,1,MMP2
cellular response to amyloid-beta,GO:1904646,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
cellular response to antibiotic,GO:0071236,"Lupus Erythematosus, Systemic",MESH:D008180,1,Isoniazid,1,IL10
cellular response to antibiotic,GO:0071236,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
cellular response to ATP,GO:0071318,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,P2RY12|PTGS2
cellular response to cadmium ion,GO:0071276,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
cellular response to cadmium ion,GO:0071276,Lupus Nephritis,MESH:D008181,0,,1,MMP9
cellular response to calcium ion,GO:0071277,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CRP
cellular response to cell-matrix adhesion,GO:0071460,Lupus Nephritis,MESH:D008181,0,,1,MMP9
cellular response to chemical stimulus,GO:0070887,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
cellular response to chemokine,GO:1990869,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SH2B3
cellular response to cisplatin,GO:0072719,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
cellular response to cisplatin,GO:0072719,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cellular response to cisplatin,GO:0072719,"Lupus Erythematosus, Systemic",MESH:D008180,7,Aspirin|Celecoxib|Chloroquine|Diclofenac|Ibuprofen|Indomethacin|Mefenamic Acid,0,
cellular response to cobalt ion,GO:0071279,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
cellular response to cobalt ion,GO:0071279,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to cocaine,GO:0071314,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cocaine,0,
cellular response to cytokine stimulus,GO:0071345,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,FAS|IL6|STAT4
cellular response to cytokine stimulus,GO:0071345,Lupus Nephritis,MESH:D008181,0,,4,FAS|MMP2|MMP9|STAT1
cellular response to dexamethasone stimulus,GO:0071549,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
cellular response to DNA damage stimulus,GO:0006974,Chilblain lupus 1,MESH:C535924,0,,2,SAMHD1|TREX1
cellular response to DNA damage stimulus,GO:0006974,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
cellular response to DNA damage stimulus,GO:0006974,"Lupus Erythematosus, Cutaneous",MESH:D008178,4,Fluorouracil|Rifampin|Thalidomide|Valproic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,"Lupus Erythematosus, Discoid",MESH:D008179,2,Azathioprine|Thalidomide,1,OGG1
cellular response to DNA damage stimulus,GO:0006974,"Lupus Erythematosus, Systemic",MESH:D008180,19,8-Hydroxy-2'-Deoxyguanosine|Azathioprine|Cocaine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Hydralazine|Isoniazid|Melatonin|Methotrexate|Particulate Matter|Rifampin|Silicon Dioxide|Thalidomide|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vincristine,3,BLK|CTLA4|TREX1
cellular response to DNA damage stimulus,GO:0006974,Lupus Nephritis,MESH:D008181,8,Azathioprine|Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Isoniazid|Lipopolysaccharides|Niclosamide|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cellular response to DNA damage stimulus,GO:0006974,"Panniculitis, Lupus Erythematosus",MESH:D015435,2,Azathioprine|Thalidomide,0,
cellular response to estradiol stimulus,GO:0071392,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IL10|IL6
cellular response to estradiol stimulus,GO:0071392,Lupus Nephritis,MESH:D008181,0,,1,MMP2
cellular response to estrogen stimulus,GO:0071391,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
cellular response to estrogen stimulus,GO:0071391,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to ethanol,GO:0071361,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRL
cellular response to exogenous dsRNA,GO:0071360,Chilblain lupus 1,MESH:C535924,0,,1,STING1
cellular response to exogenous dsRNA,GO:0071360,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IFIH1
cellular response to fluid shear stress,GO:0071498,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTGS2
cellular response to fluid shear stress,GO:0071498,Lupus Nephritis,MESH:D008181,0,,1,MMP2
cellular response to gamma radiation,GO:0071480,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
cellular response to gamma radiation,GO:0071480,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,1,TREX1
cellular response to gamma radiation,GO:0071480,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cellular response to glucose stimulus,GO:0071333,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,NCF1
cellular response to growth factor stimulus,GO:0071363,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CAT|CLU
cellular response to heat,GO:0034605,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTGS2
cellular response to hepatocyte growth factor stimulus,GO:0035729,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IL10|IL6
cellular response to high light intensity,GO:0071486,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Dapsone,0,
cellular response to high light intensity,GO:0071486,"Lupus Erythematosus, Systemic",MESH:D008180,4,Ethosuximide|Griseofulvin|Isoniazid|Minocycline,0,
cellular response to high light intensity,GO:0071486,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Isoniazid,0,
cellular response to homocysteine,GO:1905375,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTGS2
cellular response to hormone stimulus,GO:0032870,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRL
cellular response to hydrogen peroxide,GO:0070301,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,4,ETS1|FAS|IL6|TNFAIP3
cellular response to hydrogen peroxide,GO:0070301,Lupus Nephritis,MESH:D008181,1,Pentoxifylline,1,FAS
cellular response to hydrostatic pressure,GO:0071464,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
cellular response to hydrostatic pressure,GO:0071464,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to hydroxyurea,GO:0072711,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
cellular response to hydroxyurea,GO:0072711,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
cellular response to hyperoxia,GO:0071455,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
cellular response to hyperoxia,GO:0071455,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to hypoxia,GO:0071456,"Lupus Erythematosus, Systemic",MESH:D008180,0,,4,FAS|PRL|PTGS2|TERT
cellular response to hypoxia,GO:0071456,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to inorganic substance,GO:0071241,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
cellular response to insulin stimulus,GO:0032869,Lupus Nephritis,MESH:D008181,0,,1,STAT1
cellular response to interferon-beta,GO:0035458,Chilblain lupus 1,MESH:C535924,0,,2,STING1|TREX1
cellular response to interferon-beta,GO:0035458,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
cellular response to interferon-beta,GO:0035458,Lupus Nephritis,MESH:D008181,0,,1,STAT1
cellular response to interleukin-1,GO:0071347,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,FAS|IL6
cellular response to interleukin-1,GO:0071347,Lupus Nephritis,MESH:D008181,0,,3,FAS|MMP2|MMP9
cellular response to interleukin-17,GO:0097398,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
cellular response to interleukin-18,GO:0071351,Lupus Nephritis,MESH:D008181,0,,1,IFNG
cellular response to interleukin-3,GO:0036016,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SH2B3
cellular response to interleukin-3,GO:0036016,Lupus Nephritis,MESH:D008181,0,,1,JAK1
cellular response to interleukin-4,GO:0071353,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
cellular response to interleukin-6,GO:0071354,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CRP
cellular response to interleukin-7,GO:0098761,Lupus Nephritis,MESH:D008181,0,,1,JAK1
cellular response to ionizing radiation,GO:0071479,"Lupus Erythematosus, Systemic",MESH:D008180,1,8-Hydroxy-2'-Deoxyguanosine,0,
cellular response to ionizing radiation,GO:0071479,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
cellular response to iron(III) ion,GO:0071283,Lupus Nephritis,MESH:D008181,0,,1,MMP9
cellular response to lead ion,GO:0071284,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTGS2
cellular response to leukemia inhibitory factor,GO:1990830,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SYNGR1
cellular response to light stimulus,GO:0071482,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlorpromazine,1,CD40LG
cellular response to lipopolysaccharide,GO:0071222,"Lupus Erythematosus, Systemic",MESH:D008180,0,,10,CR2|FCGR2B|IL10|IL12B|IL6|PTGS2|TLR5|TNFAIP3|TNFSF4|TNIP1
cellular response to lipopolysaccharide,GO:0071222,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,3,IFNG|MMP9|STAT1
cellular response to lipopolysaccharide,GO:0071222,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,FCGR3A
cellular response to lithium ion,GO:0071285,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
cellular response to lithium ion,GO:0071285,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to low-density lipoprotein particle stimulus,GO:0071404,Lupus Nephritis,MESH:D008181,0,,1,MMP9
cellular response to mechanical stimulus,GO:0071260,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,FAS|PTGS2|TLR5
cellular response to mechanical stimulus,GO:0071260,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to mercury ion,GO:0071288,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL4
cellular response to methotrexate,GO:0071414,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
cellular response to molecule of bacterial origin,GO:0071219,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
cellular response to muramyl dipeptide,GO:0071225,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IRF5|PTPN22
cellular response to nitric oxide,GO:0071732,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CRP
cellular response to nitrogen dioxide,GO:0035714,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNFSF4
cellular response to nitrosative stress,GO:0071500,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
cellular response to non-ionic osmotic stress,GO:0071471,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTGS2
cellular response to nutrient levels,GO:0031669,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
cellular response to oxidative stress,GO:0034599,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
cellular response to oxidative stress,GO:0034599,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
cellular response to oxidative stress,GO:0034599,"Lupus Erythematosus, Systemic",MESH:D008180,3,8-Hydroxy-2'-Deoxyguanosine|Carbamazepine|Particulate Matter,1,TREX1
cellular response to oxidative stress,GO:0034599,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cellular response to peptide hormone stimulus,GO:0071375,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CSK
cellular response to peptidoglycan,GO:0071224,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IRF5
cellular response to phenylalanine,GO:0071234,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
cellular response to phenylalanine,GO:0071234,Lupus Nephritis,MESH:D008181,0,,1,FAS
cellular response to prolactin,GO:1990646,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
cellular response to prostaglandin E stimulus,GO:0071380,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNFSF4
cellular response to radiation,GO:0071478,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
cellular response to reactive oxygen species,GO:0034614,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
cellular response to reactive oxygen species,GO:0034614,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
cellular response to reactive oxygen species,GO:0034614,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,1,TREX1
cellular response to reactive oxygen species,GO:0034614,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
cellular response to rotenone,GO:1904648,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Lupus Erythematosus, Systemic",MESH:D008180,1,Rifampin,0,
cellular response to rotenone,GO:1904648,Lupus Nephritis,MESH:D008181,1,Rifampin,0,
cellular response to sodium arsenite,GO:1903936,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
cellular response to starvation,GO:0009267,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CLEC16A
cellular response to stress,GO:0033554,"Lupus Erythematosus, Systemic",MESH:D008180,2,Aspirin|Indomethacin,0,
cellular response to testosterone stimulus,GO:0071394,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,NCF1
cellular response to tumor necrosis factor,GO:0071356,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,CD40LG|FAS|IL6
cellular response to tumor necrosis factor,GO:0071356,Lupus Nephritis,MESH:D008181,0,,2,FAS|MMP9
cellular response to type II interferon,GO:0071346,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,FAS|IL12B
cellular response to type II interferon,GO:0071346,Lupus Nephritis,MESH:D008181,0,,2,FAS|STAT1
cellular response to type I interferon,GO:0071357,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
cellular response to type I interferon,GO:0071357,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
cellular response to unfolded protein,GO:0034620,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
cellular response to UV,GO:0034644,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
cellular response to UV,GO:0034644,"Lupus Erythematosus, Systemic",MESH:D008180,2,8-Hydroxy-2'-Deoxyguanosine|Chlorpromazine,1,TREX1
cellular response to UV-A,GO:0071492,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
cellular response to UV-A,GO:0071492,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
cellular response to virus,GO:0098586,"Lupus Erythematosus, Systemic",MESH:D008180,0,,5,IFIH1|IL10|IL21|IL6|IRF5
cellular response to virus,GO:0098586,Lupus Nephritis,MESH:D008181,0,,2,IFNG|JAK1
cellular response to xenobiotic stimulus,GO:0071466,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
cellular response to xenobiotic stimulus,GO:0071466,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cellular response to xenobiotic stimulus,GO:0071466,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Particulate Matter,0,
cellular senescence,GO:0090398,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Valproic Acid,0,
cellular senescence,GO:0090398,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cellular senescence,GO:0090398,"Lupus Erythematosus, Systemic",MESH:D008180,6,Aspirin|Chloroquine|Estradiol|Folic Acid|Particulate Matter|Valproic Acid,0,
cellular sodium ion homeostasis,GO:0006883,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
cellular triglyceride homeostasis,GO:0035356,"Lupus Erythematosus, Systemic",MESH:D008180,1,Triglycerides,0,
cell volume homeostasis,GO:0006884,"Lupus Erythematosus, Systemic",MESH:D008180,1,Vincristine,0,
cell volume homeostasis,GO:0006884,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
central nervous system development,GO:0007417,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
central nervous system myelination,GO:0022010,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
central nervous system myelin maintenance,GO:0032286,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CLU
central nervous system neuron development,GO:0021954,"Lupus Erythematosus, Systemic",MESH:D008180,1,Propylthiouracil,0,
central nervous system neuron development,GO:0021954,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
centriole-centriole cohesion,GO:0010457,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CD226
centriole replication,GO:0007099,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CD226
centrosome duplication,GO:0051298,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
centrosome duplication,GO:0051298,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
centrosome separation,GO:0051299,"Lupus Erythematosus, Systemic",MESH:D008180,1,Griseofulvin,0,
ceramide biosynthetic process,GO:0046513,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
ceramide biosynthetic process,GO:0046513,Lupus Nephritis,MESH:D008181,1,Rutin,0,
cerebellum development,GO:0021549,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
cerebral cortex radial glia-guided migration,GO:0021801,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,P2RY12
cGAS/STING signaling pathway,GO:0140896,Chilblain lupus 1,MESH:C535924,0,,1,STING1
cGMP biosynthetic process,GO:0006182,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
cGMP biosynthetic process,GO:0006182,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
cGMP biosynthetic process,GO:0006182,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
chaperone-mediated protein complex assembly,GO:0051131,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CLU
chaperone-mediated protein folding,GO:0061077,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CLU
chemical synaptic transmission,GO:0007268,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cocaine|Propylthiouracil,0,
chemical synaptic transmission,GO:0007268,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
chemokine (C-C motif) ligand 11 production,GO:0071954,Lupus Nephritis,MESH:D008181,1,Methimazole,0,
chemosensory behavior,GO:0007635,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Valproic Acid,0,
chemosensory behavior,GO:0007635,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
chemosensory behavior,GO:0007635,"Lupus Erythematosus, Systemic",MESH:D008180,4,Carbamazepine|Chloroquine|Cocaine|Valproic Acid,0,
chemotaxis,GO:0006935,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Valproic Acid,0,
chemotaxis,GO:0006935,Lupus Nephritis,MESH:D008181,0,,1,C3
chloride ion homeostasis,GO:0055064,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
cholesterol biosynthetic process,GO:0006695,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Fluorouracil,0,
cholesterol biosynthetic process,GO:0006695,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cholesterol biosynthetic process,GO:0006695,"Lupus Erythematosus, Systemic",MESH:D008180,5,Amiodarone|Chloroquine|Estradiol|Isoniazid|Particulate Matter,0,
cholesterol biosynthetic process,GO:0006695,Lupus Nephritis,MESH:D008181,5,Dexamethasone|Isoniazid|Lipopolysaccharides|Methimazole|Rutin,0,
cholesterol efflux,GO:0033344,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
cholesterol efflux,GO:0033344,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cholesterol efflux,GO:0033344,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|chloroquine diphosphate,0,
cholesterol homeostasis,GO:0042632,"Lupus Erythematosus, Systemic",MESH:D008180,5,"Cholesterol, VLDL|Folic Acid|Melatonin|Particulate Matter|Tobacco Smoke Pollution",0,
cholesterol homeostasis,GO:0042632,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cholesterol metabolic process,GO:0008203,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
cholesterol metabolic process,GO:0008203,"Lupus Erythematosus, Systemic",MESH:D008180,14,"Amiodarone|Aspirin|Chloroquine|Cholesterol, VLDL|Diclofenac|Estradiol|Folic Acid|Indomethacin|Melatonin|Particulate Matter|Propylthiouracil|Tobacco Smoke Pollution|triptolide|Valproic Acid",3,CAT|IL4|TNFSF4
cholesterol metabolic process,GO:0008203,Lupus Nephritis,MESH:D008181,3,Dexamethasone|Lipopolysaccharides|Propylthiouracil,0,
choline metabolic process,GO:0019695,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
choline transport,GO:0015871,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Procainamide,0,
choline transport,GO:0015871,"Lupus Erythematosus, Systemic",MESH:D008180,1,Procainamide,0,
choline transport,GO:0015871,Lupus Nephritis,MESH:D008181,1,Procainamide,0,
chondroblast differentiation,GO:0060591,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
chondrocyte development,GO:0002063,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
chondrocyte hypertrophy,GO:0003415,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
chondrocyte proliferation,GO:0035988,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
chordate embryonic development,GO:0043009,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
chordate embryonic development,GO:0043009,Lupus Nephritis,MESH:D008181,0,,1,FAS
chorion development,GO:0060717,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
chromatin organization,GO:0006325,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IKZF1
chromatin remodeling,GO:0006338,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,2,IRAK4|PTPN22
chromosome organization,GO:0051276,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
chronic inflammatory response to antigenic stimulus,GO:0002439,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL10
ciliary basal body organization,GO:0032053,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CD226
cilium assembly,GO:0060271,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
cilium movement,GO:0003341,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
cilium organization,GO:0044782,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
circadian regulation of gene expression,GO:0032922,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
circadian rhythm,GO:0007623,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,FAS|PRL
circadian rhythm,GO:0007623,Lupus Nephritis,MESH:D008181,0,,1,FAS
"circadian sleep/wake cycle, sleep",GO:0050802,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
"circadian sleep/wake cycle, wakefulness",GO:0042746,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
circulatory system development,GO:0072359,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Particulate Matter,0,
circulatory system process,GO:0003013,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
citrulline metabolic process,GO:0000052,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
citrulline metabolic process,GO:0000052,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
cobalamin metabolic process,GO:0009235,"Lupus Erythematosus, Systemic",MESH:D008180,1,Vitamin B 12,0,
coenzyme A biosynthetic process,GO:0015937,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CSK
coenzyme A metabolic process,GO:0015936,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
cognition,GO:0050890,"Lupus Erythematosus, Systemic",MESH:D008180,3,Melatonin|Particulate Matter|Tobacco Smoke Pollution,0,
cognition,GO:0050890,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
collagen biosynthetic process,GO:0032964,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Prednisolone,0,
collagen biosynthetic process,GO:0032964,"Lupus Erythematosus, Systemic",MESH:D008180,5,Amiodarone|Melatonin|Particulate Matter|Prednisolone|Silicon Dioxide,0,
collagen biosynthetic process,GO:0032964,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Prednisolone,0,
collagen catabolic process,GO:0030574,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
collagen catabolic process,GO:0030574,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
collagen fibril organization,GO:0030199,"Lupus Erythematosus, Cutaneous",MESH:D008178,4,Fluorouracil|Prednisolone|Prednisone|Valproic Acid,0,
collagen fibril organization,GO:0030199,"Lupus Erythematosus, Systemic",MESH:D008180,12,Amiodarone|Cyclophosphamide|Folic Acid|Melatonin|Methylprednisolone|Particulate Matter|Prednisolone|Prednisone|Silicon Dioxide|Tobacco Smoke Pollution|Valproic Acid|Vincristine,0,
collagen fibril organization,GO:0030199,Lupus Nephritis,MESH:D008181,8,Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Lipopolysaccharides|Methylprednisolone|Prednisolone|Prednisone|Rutin,1,MMP9
collagen fibril organization,GO:0030199,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
collagen fibril organization,GO:0030199,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Prednisone,0,
collagen metabolic process,GO:0032963,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Silicon Dioxide,0,
collagen metabolic process,GO:0032963,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
columnar/cuboidal epithelial cell maturation,GO:0002069,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
common myeloid progenitor cell proliferation,GO:0035726,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
complement activation,GO:0006956,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,C1QA|CFB|CLU
complement activation,GO:0006956,Lupus Nephritis,MESH:D008181,1,Heparin,1,C3
"complement activation, alternative pathway",GO:0006957,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CFB|CR2
"complement activation, alternative pathway",GO:0006957,Lupus Nephritis,MESH:D008181,0,,1,C3
"complement activation, classical pathway",GO:0006958,"Lupus Erythematosus, Systemic",MESH:D008180,0,,5,C1QA|CFB|CLU|CR2|CRP
"complement activation, classical pathway",GO:0006958,Lupus Nephritis,MESH:D008181,0,,2,C3|SERPING1
complement-dependent cytotoxicity,GO:0097278,Lupus Nephritis,MESH:D008181,0,,1,C3
complement-mediated synapse pruning,GO:0150062,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,C1QA|ITGAM
complement-mediated synapse pruning,GO:0150062,Lupus Nephritis,MESH:D008181,0,,1,C3
complement-mediated synapse pruning,GO:0150062,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
complement receptor mediated signaling pathway,GO:0002430,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CR2|ITGAM
complement receptor mediated signaling pathway,GO:0002430,Lupus Nephritis,MESH:D008181,0,,1,C3
complement receptor mediated signaling pathway,GO:0002430,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
conditioned place preference,GO:1990708,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cocaine,0,
convergent extension involved in gastrulation,GO:0060027,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CSK
copper ion homeostasis,GO:0055070,"Lupus Erythematosus, Systemic",MESH:D008180,1,Penicillamine,0,
coronary vasculature development,GO:0060976,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
corpus callosum development,GO:0022038,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
corticosteroid hormone secretion,GO:0035930,"Lupus Erythematosus, Systemic",MESH:D008180,1,triptolide,0,
corticosteroid hormone secretion,GO:0035930,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
corticosterone secretion,GO:0035934,"Lupus Erythematosus, Systemic",MESH:D008180,3,Celecoxib|Indomethacin|triptolide,0,
corticotropin hormone secreting cell development,GO:0060131,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
cortisol secretion,GO:0043400,"Lupus Erythematosus, Systemic",MESH:D008180,1,triptolide,0,
cranial skeletal system development,GO:1904888,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Valproic Acid,1,TNFAIP3
creatine metabolic process,GO:0006600,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
creatine metabolic process,GO:0006600,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
creatinine metabolic process,GO:0046449,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Valproic Acid,0,
creatinine metabolic process,GO:0046449,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
creatinine metabolic process,GO:0046449,"Lupus Erythematosus, Systemic",MESH:D008180,12,Celecoxib|Chloroquine|Cyclophosphamide|Diclofenac|Folic Acid|Indomethacin|Melatonin|Methotrexate|Particulate Matter|Tacrolimus|triptolide|Valproic Acid,0,
creatinine metabolic process,GO:0046449,Lupus Nephritis,MESH:D008181,6,Cyclophosphamide|Dexamethasone|Lipopolysaccharides|Pentoxifylline|Rutin|Tacrolimus,0,
creatinine metabolic process,GO:0046449,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cyclooxygenase pathway,GO:0019371,"Lupus Erythematosus, Systemic",MESH:D008180,3,Celecoxib|Indomethacin|Tobacco Smoke Pollution,1,PTGS2
cyclooxygenase pathway,GO:0019371,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cysteine metabolic process,GO:0006534,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
cysteine metabolic process,GO:0006534,"Lupus Erythematosus, Systemic",MESH:D008180,1,Propylthiouracil,0,
cysteine metabolic process,GO:0006534,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
cytokine-mediated signaling pathway,GO:0019221,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|tofacitinib,6,IL12B|IL21R|IL6|IRAK4|IRF5|STAT4
cytokine-mediated signaling pathway,GO:0019221,Lupus Nephritis,MESH:D008181,0,,2,JAK1|STAT1
cytokine production,GO:0001816,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CD226|IRAK4
cytokine production involved in immune response,GO:0002367,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Tobacco Smoke Pollution,0,
cytokine production involved in inflammatory response,GO:0002534,"Lupus Erythematosus, Systemic",MESH:D008180,4,Particulate Matter|Silicon Dioxide|Tobacco Smoke Pollution|tofacitinib,0,
cytokine production involved in inflammatory response,GO:0002534,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cytolysis,GO:0019835,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cytoplasmic sequestering of NF-kappaB,GO:0007253,"Lupus Erythematosus, Systemic",MESH:D008180,1,Celecoxib,0,
cytoplasmic sequestering of NF-kappaB,GO:0007253,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
cytoplasmic sequestering of transcription factor,GO:0042994,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
cytoplasmic sequestering of transcription factor,GO:0042994,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
cytoplasmic sequestering of transcription factor,GO:0042994,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
cytosine metabolic process,GO:0019858,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
"cytoskeletal rearrangement involved in phagocytosis, engulfment",GO:0060097,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
cytoskeleton organization,GO:0007010,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,HLA-DRB1|TNFAIP3
cytosolic pattern recognition receptor signaling pathway,GO:0002753,Chilblain lupus 1,MESH:C535924,0,,1,STING1
cytosolic pattern recognition receptor signaling pathway,GO:0002753,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IFIH1
dATP catabolic process,GO:0046061,Chilblain lupus 1,MESH:C535924,0,,1,SAMHD1
dATP catabolic process,GO:0046061,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
decidualization,GO:0046697,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,1,PTGS2
defense response,GO:0006952,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,FCGR2B|STAT4|TNIP1
defense response,GO:0006952,Lupus Nephritis,MESH:D008181,0,,1,STAT1
defense response to bacterium,GO:0042742,"Lupus Erythematosus, Systemic",MESH:D008180,0,,4,ANXA3|CFB|IL10|NCF1
defense response to bacterium,GO:0042742,Lupus Nephritis,MESH:D008181,0,,1,IFNG
defense response to fungus,GO:0050832,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,NCF1
defense response to Gram-negative bacterium,GO:0050829,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IL12B|IL6
defense response to Gram-positive bacterium,GO:0050830,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,3,CRP|IL6|NCF1
defense response to Gram-positive bacterium,GO:0050830,Lupus Nephritis,MESH:D008181,0,,1,IFNG
defense response to nematode,GO:0002215,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNFSF4
defense response to protozoan,GO:0042832,"Lupus Erythematosus, Systemic",MESH:D008180,0,,4,IL10|IL12B|IL4|IL6
defense response to protozoan,GO:0042832,Lupus Nephritis,MESH:D008181,0,,1,IFNG
defense response to virus,GO:0051607,Chilblain lupus 1,MESH:C535924,0,,3,SAMHD1|STING1|TREX1
defense response to virus,GO:0051607,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
defense response to virus,GO:0051607,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,6,IFIH1|IL12B|IL21|IL6|IRF5|TREX1
defense response to virus,GO:0051607,Lupus Nephritis,MESH:D008181,0,,2,IFNG|STAT1
delamination,GO:0060232,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
dendrite arborization,GO:0140059,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
dendrite arborization,GO:0140059,"Lupus Erythematosus, Systemic",MESH:D008180,3,Particulate Matter|Tacrolimus|Valproic Acid,0,
dendrite arborization,GO:0140059,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Tacrolimus,0,
dendrite development,GO:0016358,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,1,FCGR2B
dendrite extension,GO:0097484,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Particulate Matter,0,
dendrite regeneration,GO:0031104,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
dendrite regeneration,GO:0031104,Lupus Nephritis,MESH:D008181,0,,1,FAS
dendritic cell antigen processing and presentation,GO:0002468,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,FCGR3A
dendritic cell differentiation,GO:0097028,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,BLK|CD40LG|IL4
dendritic cell differentiation,GO:0097028,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
dendritic cell homeostasis,GO:0036145,"Lupus Erythematosus, Systemic",MESH:D008180,1,triptolide,0,
dendritic cell migration,GO:0036336,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
dendritic cell migration,GO:0036336,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
dendritic cell migration,GO:0036336,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chloroquine|Melatonin|Particulate Matter,0,
dendritic spine development,GO:0060996,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
dendritic spine morphogenesis,GO:0060997,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
dentate gyrus development,GO:0021542,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
dentate gyrus development,GO:0021542,"Lupus Erythematosus, Systemic",MESH:D008180,2,Propylthiouracil|Valproic Acid,0,
dentate gyrus development,GO:0021542,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
deoxycytidine metabolic process,GO:0046092,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
deoxyguanosine biosynthetic process,GO:0042452,"Lupus Erythematosus, Systemic",MESH:D008180,1,8-Hydroxy-2'-Deoxyguanosine,0,
deoxyguanosine metabolic process,GO:0042453,"Lupus Erythematosus, Systemic",MESH:D008180,1,8-Hydroxy-2'-Deoxyguanosine,0,
deoxyribonucleoside metabolic process,GO:0009120,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
deoxyribonucleotide catabolic process,GO:0009264,Chilblain lupus 1,MESH:C535924,0,,1,SAMHD1
deoxyribonucleotide catabolic process,GO:0009264,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
dephosphorylation,GO:0016311,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTPN22
depurination,GO:0045007,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
depyrimidination,GO:0045008,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
detection of bacterium,GO:0016045,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,HLA-DRB1
detection of cAMP,GO:0031319,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
detection of cAMP,GO:0031319,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
detection of cAMP,GO:0031319,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
detection of chemical stimulus involved in sensory perception of bitter taste,GO:0001580,"Lupus Erythematosus, Systemic",MESH:D008180,1,Propylthiouracil,0,
detection of chemical stimulus involved in sensory perception of bitter taste,GO:0001580,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Lupus Erythematosus, Systemic",MESH:D008180,2,Celecoxib|Indomethacin,0,
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
detection of oxidative stress,GO:0070994,"Lupus Erythematosus, Cutaneous",MESH:D008178,5,Chloroquine|Dapsone|Fluorouracil|Rifampin|Valproic Acid,0,
detection of oxidative stress,GO:0070994,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
detection of oxidative stress,GO:0070994,"Lupus Erythematosus, Systemic",MESH:D008180,27,8-Hydroxy-2'-Deoxyguanosine|Amiodarone|Aspirin|Carbamazepine|Chloroquine|Chlorpromazine|Cyclophosphamide|Estradiol|Folic Acid|Homocysteine|Indomethacin|Isoniazid|Melatonin|Methotrexate|Methyldopa|Mycophenolic Acid|Particulate Matter|Penicillamine|Ranitidine|Rifampin|Silicon Dioxide|Thiobarbituric Acid Reactive Substances|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vincristine|Vitamin B 12,0,
detection of oxidative stress,GO:0070994,Lupus Nephritis,MESH:D008181,7,Cyclophosphamide|Dexamethasone|Isoniazid|Lipopolysaccharides|Mycophenolic Acid|Rifampin|Rutin,0,
detection of oxidative stress,GO:0070994,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
detection of renal blood flow,GO:0002000,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
detection of symbiotic bacterium,GO:0009604,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Lupus Erythematosus, Systemic",MESH:D008180,1,Vincristine,0,
detection of virus,GO:0009597,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IFIH1
determination of adult lifespan,GO:0008340,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
determination of adult lifespan,GO:0008340,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,2,CAT|TREX1
detoxification of arsenic-containing substance,GO:0071722,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
developmental growth,GO:0048589,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Tobacco Smoke Pollution,0,
developmental process,GO:0032502,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Particulate Matter,0,
developmental process involved in reproduction,GO:0003006,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
developmental process involved in reproduction,GO:0003006,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
dGTP catabolic process,GO:0006203,Chilblain lupus 1,MESH:C535924,0,,1,SAMHD1
dGTP catabolic process,GO:0006203,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
dicarboxylic acid transport,GO:0006835,"Lupus Erythematosus, Systemic",MESH:D008180,1,Celecoxib,0,
diestrus,GO:0060207,"Lupus Erythematosus, Systemic",MESH:D008180,1,triptolide,0,
dihydrofolate biosynthetic process,GO:0006761,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
dipeptide import across plasma membrane,GO:0140206,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SLC15A4
DNA biosynthetic process,GO:0071897,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,1,TERT
DNA biosynthetic process,GO:0071897,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
DNA catabolic process,GO:0006308,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
DNA catabolic process,GO:0006308,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Fluorouracil|Quinacrine,0,
DNA catabolic process,GO:0006308,"Lupus Erythematosus, Systemic",MESH:D008180,7,8-Hydroxy-2'-Deoxyguanosine|Aspirin|Chlorpromazine|Nitrofurantoin|Particulate Matter|Quinacrine|Silicon Dioxide,3,DNASE1|DNASE1L3|TREX1
DNA catabolic process,GO:0006308,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Lupus Erythematosus, Systemic",MESH:D008180,10,8-Hydroxy-2'-Deoxyguanosine|Carbamazepine|Chloroquine|Cyclophosphamide|Isoniazid|Melatonin|Particulate Matter|Silicon Dioxide|Valproic Acid|Vitamin B 12,0,
"DNA catabolic process, endonucleolytic",GO:0000737,Lupus Nephritis,MESH:D008181,3,Cyclophosphamide|Isoniazid|Lipopolysaccharides,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
DNA damage checkpoint signaling,GO:0000077,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
DNA damage checkpoint signaling,GO:0000077,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
DNA duplex unwinding,GO:0032508,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
DNA duplex unwinding,GO:0032508,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
DNA hypomethylation,GO:0044028,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Penicillamine,0,
DNA hypomethylation,GO:0044028,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
DNA integration,GO:0015074,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,TCF7|TLR5
DNA metabolic process,GO:0006259,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
DNA metabolic process,GO:0006259,"Lupus Erythematosus, Systemic",MESH:D008180,3,8-Hydroxy-2'-Deoxyguanosine|Isoniazid|Tobacco Smoke Pollution,2,DNASE1L3|TREX1
DNA metabolic process,GO:0006259,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
DNA methylation,GO:0006306,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Procainamide|Valproic Acid,0,
DNA methylation,GO:0006306,"Lupus Erythematosus, Systemic",MESH:D008180,10,Cocaine|Estradiol|Folic Acid|Homocysteine|Hydralazine|Particulate Matter|Procainamide|Tobacco Smoke Pollution|Valproic Acid|Vitamin B 12,0,
DNA methylation,GO:0006306,Lupus Nephritis,MESH:D008181,3,Lipopolysaccharides|Niclosamide|Procainamide,0,
DNA methylation on cytosine,GO:0032776,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Folic Acid,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Lupus Erythematosus, Systemic",MESH:D008180,5,Estradiol|Folic Acid|Particulate Matter|Tobacco Smoke Pollution|Vitamin B 12,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
DNA modification,GO:0006304,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
DNA modification,GO:0006304,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Fluorouracil|Quinacrine|Valproic Acid,0,
DNA modification,GO:0006304,"Lupus Erythematosus, Systemic",MESH:D008180,9,8-Hydroxy-2'-Deoxyguanosine|Aspirin|Chlordecone|Folic Acid|Methotrexate|Particulate Matter|Quinacrine|Tobacco Smoke Pollution|Valproic Acid,1,TREX1
DNA modification,GO:0006304,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
DNA recombination,GO:0006310,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
DNA recombination,GO:0006310,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,TCF7|TREX1
DNA repair,GO:0006281,Chilblain lupus 1,MESH:C535924,0,,2,SAMHD1|TREX1
DNA repair,GO:0006281,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
DNA repair,GO:0006281,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
DNA repair,GO:0006281,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,2,CLEC16A|TREX1
DNA replication,GO:0006260,Chilblain lupus 1,MESH:C535924,0,,2,SAMHD1|TREX1
DNA replication,GO:0006260,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
DNA replication,GO:0006260,"Lupus Erythematosus, Systemic",MESH:D008180,2,Celecoxib|Silicon Dioxide,1,TREX1
DNA strand elongation,GO:0022616,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TERT
DNA strand resection involved in replication fork processing,GO:0110025,Chilblain lupus 1,MESH:C535924,0,,1,SAMHD1
DNA strand resection involved in replication fork processing,GO:0110025,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
DNA synthesis involved in DNA replication,GO:0090592,"Lupus Erythematosus, Systemic",MESH:D008180,2,Homocysteine|Indomethacin,0,
DNA synthesis involved in mitotic DNA replication,GO:1904860,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
DNA synthesis involved in UV-damage excision repair,GO:1904161,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
DNA synthesis involved in UV-damage excision repair,GO:1904161,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
DNA-templated transcription,GO:0006351,Lupus Nephritis,MESH:D008181,0,,1,STAT1
dopamine biosynthetic process,GO:0042416,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cocaine|Melatonin|Minocycline,0,
dopamine metabolic process,GO:0042417,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Valproic Acid,0,
dopamine metabolic process,GO:0042417,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
dopamine metabolic process,GO:0042417,"Lupus Erythematosus, Systemic",MESH:D008180,4,Chloroquine|Indomethacin|Particulate Matter|Valproic Acid,0,
dopaminergic neuron differentiation,GO:0071542,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Tobacco Smoke Pollution,0,
dopamine secretion,GO:0014046,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
dopamine uptake,GO:0090494,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cocaine,0,
dopamine uptake,GO:0090494,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
double-strand break repair involved in meiotic recombination,GO:1990918,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlordecone,0,
double-strand break repair via homologous recombination,GO:0000724,Chilblain lupus 1,MESH:C535924,0,,1,SAMHD1
double-strand break repair via homologous recombination,GO:0000724,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
double-strand break repair via homologous recombination,GO:0000724,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
doxorubicin transport,GO:1900753,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
doxorubicin transport,GO:1900753,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
doxorubicin transport,GO:1900753,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
D-ribose metabolic process,GO:0006014,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
drinking behavior,GO:0042756,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Fluorouracil|Valproic Acid,0,
drinking behavior,GO:0042756,"Lupus Erythematosus, Systemic",MESH:D008180,2,Methyldopa|Valproic Acid,0,
ear development,GO:0043583,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
early endosome to late endosome transport,GO:0045022,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PXK
ectodermal cell differentiation,GO:0010668,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,ITGAM
ectodermal cell differentiation,GO:0010668,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
electron transport chain,GO:0022900,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cocaine|Melatonin|Particulate Matter,0,
embryo development,GO:0009790,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Fluorouracil|Thalidomide|Valproic Acid,0,
embryo development,GO:0009790,"Lupus Erythematosus, Discoid",MESH:D008179,1,Thalidomide,0,
embryo development,GO:0009790,"Lupus Erythematosus, Systemic",MESH:D008180,9,Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Metoprolol|Particulate Matter|Propylthiouracil|Thalidomide|Valproic Acid,0,
embryo development,GO:0009790,Lupus Nephritis,MESH:D008181,5,Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Niclosamide|Propylthiouracil,0,
embryo development,GO:0009790,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
embryo development,GO:0009790,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
embryo development ending in birth or egg hatching,GO:0009792,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
embryo implantation,GO:0007566,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,1,PTGS2
embryo implantation,GO:0007566,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,2,MMP2|MMP9
embryonic body morphogenesis,GO:0010172,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
embryonic brain development,GO:1990403,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
embryonic cleavage,GO:0040016,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
embryonic cleavage,GO:0040016,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Lipopolysaccharides,0,
embryonic cleavage,GO:0040016,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
embryonic digestive tract development,GO:0048566,"Lupus Erythematosus, Systemic",MESH:D008180,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
embryonic digestive tract morphogenesis,GO:0048557,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
embryonic genitalia morphogenesis,GO:0030538,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
embryonic heart tube formation,GO:0003144,Lupus Nephritis,MESH:D008181,0,,1,MMP2
embryonic hemopoiesis,GO:0035162,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SH2B3
embryonic hindgut morphogenesis,GO:0048619,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
embryonic morphogenesis,GO:0048598,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
embryonic morphogenesis,GO:0048598,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
embryonic placenta development,GO:0001892,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,PRDM1
embryonic placenta morphogenesis,GO:0060669,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
embryonic placenta morphogenesis,GO:0060669,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
embryonic skeletal system development,GO:0048706,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
endochondral ossification,GO:0001958,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
endocrine pancreas development,GO:0031018,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CLU|IL6
endocytic recycling,GO:0032456,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
endocytosis,GO:0006897,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Prednisolone,0,
endocytosis,GO:0006897,"Lupus Erythematosus, Systemic",MESH:D008180,1,Prednisolone,0,
endocytosis,GO:0006897,Lupus Nephritis,MESH:D008181,3,Lipopolysaccharides|Niclosamide|Prednisolone,0,
endodermal cell differentiation,GO:0035987,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
endoplasmic reticulum cisternal network maintenance,GO:0071785,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
endoplasmic reticulum unfolded protein response,GO:0030968,Lupus Nephritis,MESH:D008181,0,,1,IFNG
endosomal transport,GO:0016197,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CLEC16A
endosome lysis involved in viral entry into host cell,GO:0075514,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
endosome lysis involved in viral entry into host cell,GO:0075514,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
endosome lysis involved in viral entry into host cell,GO:0075514,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
endosome organization,GO:0007032,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Hydroxychloroquine,0,
endosome organization,GO:0007032,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Hydroxychloroquine,0,
endosome organization,GO:0007032,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Hydroxychloroquine,0,
endosome to lysosome transport,GO:0008333,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CLEC16A|PXK
endothelial cell apoptotic process,GO:0072577,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL10
endothelial cell-cell adhesion,GO:0071603,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
endothelial to hematopoietic transition,GO:0098508,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Fluorouracil|Thalidomide,0,
endothelial to hematopoietic transition,GO:0098508,"Lupus Erythematosus, Discoid",MESH:D008179,1,Thalidomide,0,
endothelial to hematopoietic transition,GO:0098508,"Lupus Erythematosus, Systemic",MESH:D008180,1,Thalidomide,0,
endothelial to hematopoietic transition,GO:0098508,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
endothelial tube formation,GO:0120331,Lupus Nephritis,MESH:D008181,1,Protein Kinase Inhibitors,0,
endothelial tube lumen extension,GO:0097498,Lupus Nephritis,MESH:D008181,1,Protein Kinase Inhibitors,0,
endothelial tube lumen extension involved in blood vessel lumen ensheathment,GO:1902355,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
endothelin receptor signaling pathway,GO:0086100,"Lupus Erythematosus, Systemic",MESH:D008180,2,Celecoxib|Particulate Matter,0,
energy derivation by oxidation of organic compounds,GO:0015980,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Protein Kinase Inhibitors,0,
energy reserve metabolic process,GO:0006112,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
entry of bacterium into host cell,GO:0035635,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
enzyme-linked receptor protein signaling pathway,GO:0007167,Lupus Nephritis,MESH:D008181,0,,1,JAK1
eosinophil activation involved in immune response,GO:0002278,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
eosinophil extravasation,GO:0072682,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
eosinophil extravasation,GO:0072682,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
eosinophil homeostasis,GO:1990959,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
eosinophil migration,GO:0072677,"Lupus Erythematosus, Systemic",MESH:D008180,2,Methotrexate|Particulate Matter,0,
eosinophil migration,GO:0072677,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
ephrin receptor signaling pathway,GO:0048013,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
epiboly,GO:0090504,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
epiboly,GO:0090504,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
epiboly involved in gastrulation with mouth forming second,GO:0055113,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
epidermis development,GO:0008544,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,HLA-DRB1
epigenetic regulation of gene expression,GO:0040029,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlordecone,0,
epigenetic regulation of gene expression,GO:0040029,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
epinephrine metabolic process,GO:0042414,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
epithelial cell development,GO:0002064,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
epithelial cell proliferation,GO:0050673,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,NCF1|PRL
epithelial cell proliferation involved in salivary gland morphogenesis,GO:0060664,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
epithelial cilium movement involved in extracellular fluid movement,GO:0003351,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
epithelial fluid transport,GO:0042045,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
epithelial structure maintenance,GO:0010669,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Tobacco Smoke Pollution,1,CSK
epithelial structure maintenance,GO:0010669,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
epithelial to mesenchymal transition,GO:0001837,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Silicon Dioxide,0,
epithelial to mesenchymal transition,GO:0001837,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Niclosamide,0,
epithelium development,GO:0060429,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,STAT4|TCF7
epithelium development,GO:0060429,Lupus Nephritis,MESH:D008181,0,,1,MMP9
ERK1 and ERK2 cascade,GO:0070371,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Sertraline,0,
ER overload response,GO:0006983,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
erythrocyte aggregation,GO:0034117,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
erythrocyte development,GO:0048821,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SH2B3
erythrocyte differentiation,GO:0030218,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cyclophosphamide|Folic Acid|Metoprolol,1,IKZF1
erythrocyte differentiation,GO:0030218,Lupus Nephritis,MESH:D008181,2,arsenic disulfide|Cyclophosphamide,0,
erythrocyte differentiation,GO:0030218,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
erythrocyte homeostasis,GO:0034101,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
erythrocyte homeostasis,GO:0034101,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cyclophosphamide|Ibuprofen|Indomethacin,0,
erythrocyte homeostasis,GO:0034101,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
erythrocyte homeostasis,GO:0034101,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
erythrocyte maturation,GO:0043249,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TERT
erythromycin metabolic process,GO:1901113,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
establishment of cell polarity,GO:0030010,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
establishment of cell polarity,GO:0030010,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Lupus Erythematosus, Systemic",MESH:D008180,3,Ibuprofen|Particulate Matter|Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
establishment of localization in cell,GO:0051649,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,FCGR2B|P2RY12
establishment of localization in cell,GO:0051649,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
establishment of meiotic spindle localization,GO:0051295,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
establishment of organelle localization,GO:0051656,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
establishment of protein localization,GO:0045184,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
establishment of protein localization,GO:0045184,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IKZF1|TREX1
establishment of protein localization to chromatin,GO:0071169,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
establishment of protein localization to plasma membrane,GO:0061951,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Prednisone,0,
establishment of protein localization to plasma membrane,GO:0061951,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
establishment of protein localization to plasma membrane,GO:0061951,"Lupus Erythematosus, Systemic",MESH:D008180,4,Chloroquine|Methylprednisolone|Prednisone|triptolide,0,
establishment of protein localization to plasma membrane,GO:0061951,Lupus Nephritis,MESH:D008181,5,Dexamethasone|Methylprednisolone|Nandrolone|Niclosamide|Prednisone,0,
establishment of protein localization to plasma membrane,GO:0061951,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Prednisone,0,
establishment of protein localization to telomere,GO:0070200,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TERT
establishment of protein localization to vacuole,GO:0072666,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNFAIP3
establishment of Sertoli cell barrier,GO:0097368,"Lupus Erythematosus, Systemic",MESH:D008180,1,triptolide,0,
establishment of skin barrier,GO:0061436,"Lupus Erythematosus, Systemic",MESH:D008180,2,Indomethacin|Tobacco Smoke Pollution,0,
establishment or maintenance of epithelial cell apical/basal polarity,GO:0045197,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CSK
estradiol secretion,GO:0035938,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|triptolide,0,
estradiol secretion,GO:0035938,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
estrogen biosynthetic process,GO:0006703,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
estrogen biosynthetic process,GO:0006703,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
estrogen metabolic process,GO:0008210,"Lupus Erythematosus, Systemic",MESH:D008180,5,Cyclophosphamide|Estradiol|Ibuprofen|Melatonin|Methotrexate,0,
estrogen metabolic process,GO:0008210,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
estrogen metabolic process,GO:0008210,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
estrogen secretion,GO:0035937,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
estrone secretion,GO:0035943,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
estrone secretion,GO:0035943,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
estrous cycle,GO:0044849,"Lupus Erythematosus, Systemic",MESH:D008180,3,Estradiol|triptolide|Vincristine,2,CLU|ETS1
estrus,GO:0060209,"Lupus Erythematosus, Systemic",MESH:D008180,2,Ibuprofen|triptolide,0,
ethanolamine metabolic process,GO:0006580,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
ether lipid biosynthetic process,GO:0008611,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
ether lipid metabolic process,GO:0046485,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
excitatory postsynaptic potential,GO:0060079,"Lupus Erythematosus, Systemic",MESH:D008180,3,Carbamazepine|Cocaine|Tacrolimus,0,
excitatory postsynaptic potential,GO:0060079,Lupus Nephritis,MESH:D008181,1,Tacrolimus,0,
excretion,GO:0007588,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
exosomal secretion,GO:1990182,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
exploration behavior,GO:0035640,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
exploration behavior,GO:0035640,"Lupus Erythematosus, Systemic",MESH:D008180,5,Melatonin|Minocycline|Particulate Matter|Tacrolimus|Valproic Acid,0,
exploration behavior,GO:0035640,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Tacrolimus,0,
export across plasma membrane,GO:0140115,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
export from cell,GO:0140352,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
extracellular matrix assembly,GO:0085029,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
extracellular matrix disassembly,GO:0022617,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
extracellular matrix organization,GO:0030198,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
extraembryonic membrane development,GO:1903867,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
extrinsic apoptotic signaling pathway,GO:0097191,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Sertraline,0,
extrinsic apoptotic signaling pathway,GO:0097191,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,FAS|IL4
extrinsic apoptotic signaling pathway,GO:0097191,Lupus Nephritis,MESH:D008181,0,,2,FAS|IFNG
extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,FAS|IL4
extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,Lupus Nephritis,MESH:D008181,0,,1,FAS
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,Lupus Nephritis,MESH:D008181,0,,1,FAS
eye development,GO:0001654,"Lupus Erythematosus, Systemic",MESH:D008180,3,Melatonin|Metoprolol|Propylthiouracil,0,
eye development,GO:0001654,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
eyelid development in camera-type eye,GO:0061029,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
eye photoreceptor cell development,GO:0042462,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
face development,GO:0060324,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
face morphogenesis,GO:0060325,Lupus Nephritis,MESH:D008181,0,,1,MMP2
fasciculation of motor neuron axon,GO:0097156,Lupus Nephritis,MESH:D008181,0,,1,MMP2
Fas signaling pathway,GO:0036337,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
Fas signaling pathway,GO:0036337,Lupus Nephritis,MESH:D008181,0,,1,FAS
fat cell differentiation,GO:0045444,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
fat cell differentiation,GO:0045444,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
fat cell differentiation,GO:0045444,"Lupus Erythematosus, Systemic",MESH:D008180,6,Chloroquine|Estradiol|Indomethacin|Isoniazid|Thiobarbituric Acid Reactive Substances|Triglycerides,0,
fat cell differentiation,GO:0045444,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Isoniazid,0,
fat cell proliferation,GO:0070341,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cyclophosphamide|Methylprednisolone|Particulate Matter,0,
fat cell proliferation,GO:0070341,Lupus Nephritis,MESH:D008181,3,Cyclophosphamide|Lipopolysaccharides|Methylprednisolone,0,
fat cell proliferation,GO:0070341,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
fat pad development,GO:0060613,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
fat pad development,GO:0060613,"Lupus Erythematosus, Systemic",MESH:D008180,1,Rifampin,0,
fat pad development,GO:0060613,Lupus Nephritis,MESH:D008181,1,Rifampin,0,
fatty acid beta-oxidation,GO:0006635,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Protein Kinase Inhibitors,0,
fatty acid biosynthetic process,GO:0006633,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Particulate Matter,0,
fatty acid biosynthetic process,GO:0006633,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
fatty acid metabolic process,GO:0006631,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Hydroxychloroquine,0,
fatty acid metabolic process,GO:0006631,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
fatty acid metabolic process,GO:0006631,"Lupus Erythematosus, Systemic",MESH:D008180,6,Amiodarone|Folic Acid|Hydroxychloroquine|Indomethacin|Particulate Matter|Vitamin B 12,0,
fatty acid metabolic process,GO:0006631,Lupus Nephritis,MESH:D008181,0,,1,C3
fatty acid oxidation,GO:0019395,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Fluorouracil|Rifampin,0,
fatty acid oxidation,GO:0019395,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
fatty acid oxidation,GO:0019395,"Lupus Erythematosus, Systemic",MESH:D008180,7,Amiodarone|Aspirin|Chloroquine|Diclofenac|Indomethacin|Methotrexate|Rifampin,0,
fatty acid oxidation,GO:0019395,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Rifampin,0,
fatty acid transport,GO:0015908,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
Fc-epsilon receptor signaling pathway,GO:0038095,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,FCGR3A
Fc-gamma receptor signaling pathway,GO:0038094,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,FCGR2A|FCGR2B
Fc-gamma receptor signaling pathway,GO:0038094,Lupus Nephritis,MESH:D008181,0,,1,FCGR3B
Fc-gamma receptor signaling pathway,GO:0038094,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,2,FCGR3A|FCGR3B
Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038096,Lupus Nephritis,MESH:D008181,0,,1,IFNG
Fc receptor-mediated immune complex endocytosis,GO:0160006,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
Fc receptor-mediated immune complex endocytosis,GO:0160006,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,FCGR3A
Fc receptor mediated stimulatory signaling pathway,GO:0002431,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,BLK
fear response,GO:0042596,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
feeding behavior,GO:0007631,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
feeding behavior,GO:0007631,"Lupus Erythematosus, Systemic",MESH:D008180,3,Propylthiouracil|Tobacco Smoke Pollution|Valproic Acid,0,
feeding behavior,GO:0007631,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
female gonad development,GO:0008585,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
female mating behavior,GO:0060180,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
female pregnancy,GO:0007565,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,ETS1|IL4|PRL
female pregnancy,GO:0007565,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,1,MMP2
ferroptosis,GO:0097707,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
ferroptosis,GO:0097707,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
ferroptosis,GO:0097707,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chloroquine|Particulate Matter|Silicon Dioxide,0,
fertilization,GO:0009566,"Lupus Erythematosus, Systemic",MESH:D008180,4,Cyclophosphamide|Isoniazid|Melatonin|Tobacco Smoke Pollution,0,
fertilization,GO:0009566,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Isoniazid,0,
fertilization,GO:0009566,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
fibrinolysis,GO:0042730,Lupus Nephritis,MESH:D008181,0,,1,SERPING1
fibroblast activation,GO:0072537,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Silicon Dioxide,0,
fin development,GO:0033333,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
fin morphogenesis,GO:0033334,Lupus Nephritis,MESH:D008181,0,,1,MMP9
fin regeneration,GO:0031101,Lupus Nephritis,MESH:D008181,0,,1,MMP9
flagellated sperm motility,GO:0030317,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
flagellated sperm motility,GO:0030317,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
focal adhesion assembly,GO:0048041,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
folate import across plasma membrane,GO:1904447,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
folic acid metabolic process,GO:0046655,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Methotrexate,0,
folic acid metabolic process,GO:0046655,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
folic acid transport,GO:0015884,"Lupus Erythematosus, Systemic",MESH:D008180,3,Folic Acid|Homocysteine|Methotrexate,0,
folic acid transport,GO:0015884,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
follicle-stimulating hormone secretion,GO:0046884,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
follicular B cell differentiation,GO:0002316,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
follicular dendritic cell activation,GO:0002266,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
forebrain development,GO:0030900,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,2,IKZF1|ITGAM
forebrain development,GO:0030900,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
forebrain morphogenesis,GO:0048853,"Lupus Erythematosus, Systemic",MESH:D008180,1,Homocysteine,0,
forebrain neuron development,GO:0021884,"Lupus Erythematosus, Systemic",MESH:D008180,1,Propylthiouracil,0,
forebrain neuron development,GO:0021884,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
formate metabolic process,GO:0015942,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Hydroxychloroquine,0,
formate metabolic process,GO:0015942,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
formate metabolic process,GO:0015942,"Lupus Erythematosus, Systemic",MESH:D008180,1,Hydroxychloroquine,0,
fructose biosynthetic process,GO:0046370,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
fructose biosynthetic process,GO:0046370,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
fructose biosynthetic process,GO:0046370,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
G0 to G1 transition,GO:0045023,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Fluorouracil,0,
G0 to G1 transition,GO:0045023,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
G0 to G1 transition,GO:0045023,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Folic Acid,0,
G0 to G1 transition,GO:0045023,Lupus Nephritis,MESH:D008181,2,arsenic disulfide|Dexamethasone,0,
G1 phase,GO:0051318,"Lupus Erythematosus, Systemic",MESH:D008180,1,Minocycline,0,
G1/S transition of mitotic cell cycle,GO:0000082,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
G2/M transition of mitotic cell cycle,GO:0000086,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
G2/M transition of mitotic cell cycle,GO:0000086,"Lupus Erythematosus, Systemic",MESH:D008180,5,Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Melatonin,0,
G2/M transition of mitotic cell cycle,GO:0000086,Lupus Nephritis,MESH:D008181,3,arsenic disulfide|Cyclophosphamide|Dexamethasone,0,
G2/M transition of mitotic cell cycle,GO:0000086,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
G2 phase,GO:0051319,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
G2 phase,GO:0051319,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
GABAergic neuron differentiation,GO:0097154,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
galactose metabolic process,GO:0006012,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methylprednisolone,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,Lupus Nephritis,MESH:D008181,1,Methylprednisolone,0,
gamma-aminobutyric acid import,GO:0051939,"Lupus Erythematosus, Systemic",MESH:D008180,1,Metoprolol,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
gamma-delta T cell differentiation,GO:0042492,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TCF7
GDP-mannose biosynthetic process,GO:0009298,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
gene expression,GO:0010467,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chlordecone|Particulate Matter|Tobacco Smoke Pollution,3,FAS|IL6|PRDM1
gene expression,GO:0010467,Lupus Nephritis,MESH:D008181,0,,1,FAS
generation of ovulation cycle rhythm,GO:0060112,"Lupus Erythematosus, Systemic",MESH:D008180,3,Estradiol|Propylthiouracil|triptolide,0,
generation of ovulation cycle rhythm,GO:0060112,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
generation of precursor metabolites and energy,GO:0006091,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
generation of precursor metabolites and energy,GO:0006091,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
germarium-derived egg chamber formation,GO:0007293,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CSK
germ cell development,GO:0007281,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,PRDM1
germ cell proliferation,GO:0036093,"Lupus Erythematosus, Systemic",MESH:D008180,1,Propylthiouracil,0,
germ cell proliferation,GO:0036093,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
germinal center B cell differentiation,GO:0002314,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IL21|IL6
gland development,GO:0048732,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IKZF1
glial cell activation,GO:0061900,"Lupus Erythematosus, Systemic",MESH:D008180,2,Minocycline|Particulate Matter,0,
glial cell development,GO:0021782,Lupus Nephritis,MESH:D008181,0,,1,MMP2
glial cell fate commitment,GO:0021781,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
glial cell growth,GO:0042065,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
glial cell migration,GO:0008347,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,P2RY12
glomerular filtration,GO:0003094,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Nitrendipine,0,
glomerular filtration,GO:0003094,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
glomerular filtration,GO:0003094,"Lupus Erythematosus, Systemic",MESH:D008180,6,Aspirin|Chloroquine|Diclofenac|Indomethacin|Particulate Matter|Tacrolimus,0,
glomerular filtration,GO:0003094,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Tacrolimus,0,
glucagon secretion,GO:0070091,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
gluconeogenesis,GO:0006094,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Prednisone,0,
gluconeogenesis,GO:0006094,"Lupus Erythematosus, Systemic",MESH:D008180,1,Prednisone,0,
gluconeogenesis,GO:0006094,Lupus Nephritis,MESH:D008181,3,Dexamethasone|Methimazole|Prednisone,0,
gluconeogenesis,GO:0006094,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Prednisone,0,
glucose 6-phosphate metabolic process,GO:0051156,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
glucose catabolic process,GO:0006007,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Rifampin,0,
glucose catabolic process,GO:0006007,Lupus Nephritis,MESH:D008181,1,Rifampin,0,
glucose catabolic process to lactate,GO:0019659,"Lupus Erythematosus, Systemic",MESH:D008180,1,triptolide,0,
glucose homeostasis,GO:0042593,"Lupus Erythematosus, Systemic",MESH:D008180,9,Carbamazepine|Estradiol|Folic Acid|Glucocorticoids|Melatonin|Particulate Matter|Propylthiouracil|Tobacco Smoke Pollution|triptolide,1,IL6
glucose homeostasis,GO:0042593,Lupus Nephritis,MESH:D008181,4,Dexamethasone|Lipopolysaccharides|Pentoxifylline|Propylthiouracil,0,
glucose import,GO:0046323,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
glucose import,GO:0046323,"Lupus Erythematosus, Systemic",MESH:D008180,4,Particulate Matter|Tacrolimus|triptolide|Valproic Acid,0,
glucose import,GO:0046323,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Tacrolimus,0,
glucose import across plasma membrane,GO:0098708,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
glucose import across plasma membrane,GO:0098708,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
glucose import across plasma membrane,GO:0098708,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
glucose metabolic process,GO:0006006,"Lupus Erythematosus, Systemic",MESH:D008180,9,Amiodarone|Diclofenac|Folic Acid|Melatonin|Methylprednisolone|Particulate Matter|Tobacco Smoke Pollution|triptolide|Vitamin B 12,0,
glucose metabolic process,GO:0006006,Lupus Nephritis,MESH:D008181,3,Dexamethasone|Lipopolysaccharides|Methylprednisolone,0,
glucose transmembrane transport,GO:1904659,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
glutamate biosynthetic process,GO:0006537,"Lupus Erythematosus, Systemic",MESH:D008180,2,Methylprednisolone|Tobacco Smoke Pollution,0,
glutamate biosynthetic process,GO:0006537,Lupus Nephritis,MESH:D008181,1,Methylprednisolone,0,
glutamate metabolic process,GO:0006536,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Valproic Acid,0,
glutamate metabolic process,GO:0006536,Lupus Nephritis,MESH:D008181,3,arsenic disulfide|Dexamethasone|Niclosamide,0,
glutamatergic neuron differentiation,GO:1905962,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
glutamine metabolic process,GO:0006541,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Propylthiouracil,0,
glutamine metabolic process,GO:0006541,Lupus Nephritis,MESH:D008181,2,Niclosamide|Propylthiouracil,0,
glutathione biosynthetic process,GO:0006750,"Lupus Erythematosus, Cutaneous",MESH:D008178,4,Chloroquine|Fluorouracil|Rifampin|Valproic Acid,0,
glutathione biosynthetic process,GO:0006750,"Lupus Erythematosus, Discoid",MESH:D008179,2,Azathioprine|Chloroquine,0,
glutathione biosynthetic process,GO:0006750,"Lupus Erythematosus, Systemic",MESH:D008180,27,Amiodarone|Aspirin|Azathioprine|Celecoxib|Chloroquine|chloroquine diphosphate|Chlorpromazine|Cocaine|Cyclophosphamide|Diclofenac|Folic Acid|Indomethacin|Isoniazid|Melatonin|Methotrexate|Particulate Matter|Propylthiouracil|Quinidine|Ranitidine|Rifampin|Silicon Dioxide|Sulfasalazine|Tacrolimus|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vitamin B 12,0,
glutathione biosynthetic process,GO:0006750,Lupus Nephritis,MESH:D008181,12,arsenic disulfide|Azathioprine|Cyclophosphamide|Dexamethasone|Isoniazid|Lipopolysaccharides|Methimazole|Propylthiouracil|Quinidine|Rifampin|Rutin|Tacrolimus,0,
glutathione biosynthetic process,GO:0006750,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
glutathione biosynthetic process,GO:0006750,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Azathioprine,0,
glutathione catabolic process,GO:0006751,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
glutathione catabolic process,GO:0006751,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
glutathione catabolic process,GO:0006751,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Tobacco Smoke Pollution,0,
glutathione derivative biosynthetic process,GO:1901687,"Lupus Erythematosus, Systemic",MESH:D008180,5,Diclofenac|Ibuprofen|Methotrexate|Penicillamine|Silicon Dioxide,0,
glutathione metabolic process,GO:0006749,"Lupus Erythematosus, Cutaneous",MESH:D008178,5,Chloroquine|Fluorouracil|Rifampin|Sertraline|Valproic Acid,0,
glutathione metabolic process,GO:0006749,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
glutathione metabolic process,GO:0006749,"Lupus Erythematosus, Systemic",MESH:D008180,26,Aspirin|Carbamazepine|Chloroquine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Homocysteine|Ibuprofen|Indomethacin|Isoniazid|Melatonin|Methotrexate|Methylprednisolone|Nitrofurantoin|Particulate Matter|Propylthiouracil|Ranitidine|Rifampin|Silicon Dioxide|Sulfasalazine|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vincristine|Vitamin B 12,0,
glutathione metabolic process,GO:0006749,Lupus Nephritis,MESH:D008181,9,arsenic disulfide|Cyclophosphamide|Dexamethasone|Isoniazid|Lipopolysaccharides|Methylprednisolone|Propylthiouracil|Rifampin|Rutin,0,
glutathione metabolic process,GO:0006749,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
glutathione transport,GO:0034635,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
glycerol metabolic process,GO:0006071,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
glycerol metabolic process,GO:0006071,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
glycerophospholipid metabolic process,GO:0006650,"Lupus Erythematosus, Systemic",MESH:D008180,4,Folic Acid|Indomethacin|Particulate Matter|Vitamin B 12,0,
glycerophospholipid metabolic process,GO:0006650,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
glycine biosynthetic process,GO:0006545,"Lupus Erythematosus, Systemic",MESH:D008180,2,Methylprednisolone|Tobacco Smoke Pollution,0,
glycine biosynthetic process,GO:0006545,Lupus Nephritis,MESH:D008181,1,Methylprednisolone,0,
glycogen biosynthetic process,GO:0005978,"Lupus Erythematosus, Systemic",MESH:D008180,2,Diclofenac|Folic Acid,0,
glycogen biosynthetic process,GO:0005978,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
glycogen catabolic process,GO:0005980,"Lupus Erythematosus, Systemic",MESH:D008180,2,Mefenamic Acid|Methotrexate,0,
glycogen catabolic process,GO:0005980,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
glycogen metabolic process,GO:0005977,"Lupus Erythematosus, Systemic",MESH:D008180,2,Diclofenac|Particulate Matter,0,
glycolipid metabolic process,GO:0006664,"Lupus Erythematosus, Systemic",MESH:D008180,1,Triglycerides,0,
glycolytic process,GO:0006096,"Lupus Erythematosus, Systemic",MESH:D008180,5,Aspirin|Estradiol|Mefenamic Acid|Melatonin|Quinidine,0,
glycolytic process,GO:0006096,Lupus Nephritis,MESH:D008181,5,Dexamethasone|Heparin|Lipopolysaccharides|Protein Kinase Inhibitors|Quinidine,0,
glycoprotein biosynthetic process,GO:0009101,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNIP1
glycoprotein metabolic process,GO:0009100,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
glycosylation,GO:0070085,"Lupus Erythematosus, Systemic",MESH:D008180,2,Aspirin|Mycophenolic Acid,0,
glycosylation,GO:0070085,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Mycophenolic Acid,0,
Golgi disassembly,GO:0090166,"Lupus Erythematosus, Systemic",MESH:D008180,1,Griseofulvin,0,
Golgi organization,GO:0007030,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Hydroxychloroquine,0,
Golgi organization,GO:0007030,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Hydroxychloroquine,0,
Golgi organization,GO:0007030,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Hydroxychloroquine,0,
GPI anchor biosynthetic process,GO:0006506,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chlorambucil|Silicon Dioxide,0,
GPI anchor biosynthetic process,GO:0006506,Lupus Nephritis,MESH:D008181,1,Chlorambucil,0,
G protein-coupled adenosine receptor signaling pathway,GO:0001973,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,P2RY12
G protein-coupled purinergic nucleotide receptor signaling pathway,GO:0035589,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,P2RY12
G protein-coupled receptor signaling pathway,GO:0007186,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CD40LG|P2RY12
G protein-coupled receptor signaling pathway,GO:0007186,Lupus Nephritis,MESH:D008181,0,,1,C3
granuloma formation,GO:0002432,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
grooming behavior,GO:0007625,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
grooming behavior,GO:0007625,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Valproic Acid,0,
growth,GO:0040007,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
growth,GO:0040007,Lupus Nephritis,MESH:D008181,2,Diethylstilbestrol|Lipopolysaccharides,0,
growth hormone receptor signaling pathway via JAK-STAT,GO:0060397,Lupus Nephritis,MESH:D008181,0,,1,JAK1
growth involved in heart morphogenesis,GO:0003241,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
growth plate cartilage development,GO:0003417,Lupus Nephritis,MESH:D008181,0,,1,MMP9
guanine metabolic process,GO:0046098,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
hair cycle,GO:0042633,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTGS2
hatching,GO:0035188,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
hatching,GO:0035188,"Lupus Erythematosus, Systemic",MESH:D008180,7,Carbamazepine|Estradiol|Folic Acid|Isoniazid|Particulate Matter|Tobacco Smoke Pollution|Valproic Acid,0,
hatching,GO:0035188,Lupus Nephritis,MESH:D008181,2,Diethylstilbestrol|Isoniazid,0,
head development,GO:0060322,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
head development,GO:0060322,"Lupus Erythematosus, Systemic",MESH:D008180,3,Ibuprofen|Melatonin|Valproic Acid,0,
head development,GO:0060322,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Diethylstilbestrol,0,
heart contraction,GO:0060047,"Lupus Erythematosus, Systemic",MESH:D008180,4,Amiodarone|Diclofenac|Metoprolol|Particulate Matter,0,
heart development,GO:0007507,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Thalidomide,0,
heart development,GO:0007507,"Lupus Erythematosus, Discoid",MESH:D008179,1,Thalidomide,0,
heart development,GO:0007507,"Lupus Erythematosus, Systemic",MESH:D008180,6,Diclofenac|Folic Acid|Melatonin|Methotrexate|Particulate Matter|Thalidomide,2,PTPN22|TERT
heart development,GO:0007507,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
heart development,GO:0007507,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
heart formation,GO:0060914,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Homocysteine,0,
heart morphogenesis,GO:0003007,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
heart morphogenesis,GO:0003007,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CAT|TREX1
heart process,GO:0003015,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
heart process,GO:0003015,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
heart rudiment development,GO:0003313,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
heart valve development,GO:0003170,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
hematopoietic stem cell differentiation,GO:0060218,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IL6|SH2B3
hematopoietic stem cell homeostasis,GO:0061484,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,STAT4
hematopoietic stem cell migration,GO:0035701,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
hematopoietic stem cell proliferation,GO:0071425,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
hematopoietic stem cell proliferation,GO:0071425,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
hematopoietic stem cell proliferation,GO:0071425,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
heme metabolic process,GO:0042168,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
heme oxidation,GO:0006788,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Dapsone,0,
hemoglobin biosynthetic process,GO:0042541,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Particulate Matter,0,
hemoglobin metabolic process,GO:0020027,"Lupus Erythematosus, Systemic",MESH:D008180,5,Cyclophosphamide|Folic Acid|Indomethacin|Particulate Matter|Tobacco Smoke Pollution,1,CAT
hemoglobin metabolic process,GO:0020027,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Lipopolysaccharides,0,
hemoglobin metabolic process,GO:0020027,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
hemopoiesis,GO:0030097,"Lupus Erythematosus, Systemic",MESH:D008180,1,Diclofenac,4,IKZF1|IL10|SH2B3|TERT
hemopoiesis,GO:0030097,Lupus Nephritis,MESH:D008181,0,,1,JAK1
hemostasis,GO:0007599,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,P2RY12
heparan sulfate proteoglycan metabolic process,GO:0030201,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
hepatic immune response,GO:0002384,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
hepatic stellate cell activation,GO:0035733,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
hepatocyte apoptotic process,GO:0097284,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
hepatocyte apoptotic process,GO:0097284,Lupus Nephritis,MESH:D008181,0,,1,FAS
hepatocyte differentiation,GO:0070365,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
hepatocyte differentiation,GO:0070365,"Lupus Erythematosus, Systemic",MESH:D008180,1,Diclofenac,0,
hepatocyte differentiation,GO:0070365,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
hepatocyte homeostasis,GO:0036333,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
hepatocyte proliferation,GO:0072574,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,1,IL6
heterocycle metabolic process,GO:0046483,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
heterotypic cell-cell adhesion,GO:0034113,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
heterotypic cell-cell adhesion,GO:0034113,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
heterotypic cell-cell adhesion,GO:0034113,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Particulate Matter,1,ITGAM
heterotypic cell-cell adhesion,GO:0034113,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
heterotypic cell-cell adhesion,GO:0034113,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
hindbrain development,GO:0030902,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
hindlimb morphogenesis,GO:0035137,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
hippocampus development,GO:0021766,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,ANXA3
histamine biosynthetic process,GO:0001694,"Lupus Erythematosus, Systemic",MESH:D008180,1,Metoprolol,0,
histamine metabolic process,GO:0001692,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
histamine metabolic process,GO:0001692,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
histamine secretion,GO:0001821,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
histamine secretion involved in inflammatory response,GO:0002441,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Nitrendipine|pimecrolimus|Prednisolone,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Lupus Erythematosus, Systemic",MESH:D008180,6,Homocysteine|Indomethacin|Prednisolone|Ranitidine|Sulfasalazine|Tacrolimus,0,
histamine secretion mediated by immunoglobulin,GO:0097280,Lupus Nephritis,MESH:D008181,6,Dexamethasone|Diethylstilbestrol|Heparin|Lipopolysaccharides|Prednisolone|Tacrolimus,0,
histidine transport,GO:0015817,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SLC15A4
histone acetylation,GO:0016573,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
histone acetylation,GO:0016573,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
histone H2A monoubiquitination,GO:0035518,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlordecone,0,
histone H3 acetylation,GO:0043966,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Rifampin|Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
histone H3 acetylation,GO:0043966,"Lupus Erythematosus, Systemic",MESH:D008180,4,Chloroquine|Rifampin|Tobacco Smoke Pollution|Valproic Acid,0,
histone H3 acetylation,GO:0043966,Lupus Nephritis,MESH:D008181,3,Dexamethasone|Lipopolysaccharides|Rifampin,0,
histone H3 deacetylation,GO:0070932,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
histone H3-K14 acetylation,GO:0044154,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
histone H3-K23 acetylation,GO:0043972,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
histone H3-K27 acetylation,GO:0043974,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
histone H3-K27 acetylation,GO:0043974,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
histone H3-K27 trimethylation,GO:0098532,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chlordecone|Ibuprofen|Tobacco Smoke Pollution,0,
histone H3-K36 dimethylation,GO:0097676,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
histone H3-K4 acetylation,GO:0043973,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
histone H3-K4 dimethylation,GO:0044648,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
histone H3-K4 trimethylation,GO:0080182,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chlordecone|Estradiol|Tobacco Smoke Pollution,0,
histone H3-K4 trimethylation,GO:0080182,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
histone H3-K9 acetylation,GO:0043970,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Hydralazine,0,
histone H3-K9 acetylation,GO:0043970,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
histone H3-K9 dimethylation,GO:0036123,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
histone H3-K9 trimethylation,GO:0036124,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chlordecone|Melatonin,0,
histone H3-R2 methylation,GO:0034970,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cocaine,0,
histone H4 acetylation,GO:0043967,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Rifampin|Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chlordecone|Rifampin|Valproic Acid,0,
histone H4 acetylation,GO:0043967,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Rifampin,0,
histone H4 deacetylation,GO:0070933,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
histone H4-K12 acetylation,GO:0043983,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Rifampin,0,
histone H4-K12 acetylation,GO:0043983,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
histone H4-K16 acetylation,GO:0043984,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
histone H4-K20 trimethylation,GO:0034773,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
histone H4-K5 acetylation,GO:0043981,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlordecone,0,
histone H4-R3 methylation,GO:0043985,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Lupus Erythematosus, Systemic",MESH:D008180,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,Lupus Nephritis,MESH:D008181,1,Rifampin,0,
histone methylation,GO:0016571,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
histone modification,GO:0016570,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
homeostasis of number of cells,GO:0048872,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Lupus Erythematosus, Systemic",MESH:D008180,2,Indomethacin|Valproic Acid,0,
homeostasis of number of cells within a tissue,GO:0048873,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
homocysteine biosynthetic process,GO:0071268,"Lupus Erythematosus, Systemic",MESH:D008180,1,Homocysteine,0,
homocysteine metabolic process,GO:0050667,"Lupus Erythematosus, Systemic",MESH:D008180,4,Folic Acid|Homocysteine|Propylthiouracil|Vitamin B 12,0,
homocysteine metabolic process,GO:0050667,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
homologous chromosome orientation involved in meiotic metaphase I plate congression,GO:0031619,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
homotypic cell-cell adhesion,GO:0034109,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
hormone metabolic process,GO:0042445,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Lupus Erythematosus, Systemic",MESH:D008180,2,Carbamazepine|Particulate Matter,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
humoral immune response,GO:0006959,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,HLA-DRB1|IL6
humoral immune response,GO:0006959,Lupus Nephritis,MESH:D008181,0,,1,IFNG
hydrogen peroxide biosynthetic process,GO:0050665,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Fluorouracil|Prednisolone,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Lupus Erythematosus, Systemic",MESH:D008180,7,Estradiol|Folic Acid|Homocysteine|Melatonin|Particulate Matter|Prednisolone|Silicon Dioxide,1,NCF1
hydrogen peroxide biosynthetic process,GO:0050665,Lupus Nephritis,MESH:D008181,4,arsenic disulfide|Lipopolysaccharides|Prednisolone|Rutin,0,
hydrogen peroxide catabolic process,GO:0042744,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CAT
hydrogen peroxide metabolic process,GO:0042743,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Sulfasalazine,0,
hydroperoxide metabolic process,GO:2001290,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
hydroperoxide metabolic process,GO:2001290,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
hydroperoxide metabolic process,GO:2001290,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
hypersensitivity,GO:0002524,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Tobacco Smoke Pollution,0,
hypoblast development,GO:0090008,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
hypomethylation of CpG island,GO:0044029,"Lupus Erythematosus, Discoid",MESH:D008179,0,,1,OGG1
hypomethylation of CpG island,GO:0044029,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
hypomethylation of CpG island,GO:0044029,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
hypothalamus development,GO:0021854,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,ETS1
hypoxanthine metabolic process,GO:0046100,"Lupus Erythematosus, Systemic",MESH:D008180,2,Indomethacin|Melatonin,0,
icosanoid secretion,GO:0032309,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
I-kappaB kinase/NF-kappaB signaling,GO:0007249,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Protein Kinase Inhibitors,0,
I-kappaB phosphorylation,GO:0007252,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
imaginal disc eversion,GO:0007561,Lupus Nephritis,MESH:D008181,0,,1,MMP2
"imaginal disc fusion, thorax closure",GO:0046529,Lupus Nephritis,MESH:D008181,0,,1,MMP2
immune complex clearance,GO:0002434,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CLU|FCGR2B
immune complex clearance by monocytes and macrophages,GO:0002436,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
immune complex formation,GO:0097281,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
immune complex formation,GO:0097281,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
immune effector process,GO:0002252,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
immune response,GO:0006955,Chilblain lupus 1,MESH:C535924,0,,2,SAMHD1|TREX1
immune response,GO:0006955,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
immune response,GO:0006955,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,16,CD40LG|CFB|CR2|CTLA4|ETS1|FAS|HLA-DQA1|HLA-DRB1|IL10|IL21|IL4|IL6|TCF7|TLR5|TNFSF4|TREX1
immune response,GO:0006955,Lupus Nephritis,MESH:D008181,0,,4,C3|FAS|FCGR3B|IFNG
immune response,GO:0006955,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,2,FCGR3A|FCGR3B
immune response in brain or nervous system,GO:0002383,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
immune response in brain or nervous system,GO:0002383,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
immune system process,GO:0002376,Chilblain lupus 1,MESH:C535924,0,,2,SAMHD1|STING1
immune system process,GO:0002376,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
immune system process,GO:0002376,"Lupus Erythematosus, Systemic",MESH:D008180,0,,5,CFB|ETS1|IFIH1|IRAK4|IRF5
immunoglobulin mediated immune response,GO:0016064,"Lupus Erythematosus, Systemic",MESH:D008180,0,,4,CR2|FCGR2B|IL12B|IL21R
immunoglobulin production,GO:0002377,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,CD40LG|FAS|FCGR2B
immunoglobulin production,GO:0002377,Lupus Nephritis,MESH:D008181,0,,1,FAS
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,TREX1
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
import across plasma membrane,GO:0098739,"Lupus Erythematosus, Systemic",MESH:D008180,3,Amiodarone|Estradiol|Isoniazid,0,
import across plasma membrane,GO:0098739,Lupus Nephritis,MESH:D008181,2,Heparin|Isoniazid,0,
import into cell,GO:0098657,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Rifampin,0,
import into cell,GO:0098657,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
import into cell,GO:0098657,"Lupus Erythematosus, Systemic",MESH:D008180,5,Chloroquine|Chlorpromazine|Methotrexate|Particulate Matter|Rifampin,0,
import into cell,GO:0098657,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Rifampin,0,
import into nucleus,GO:0051170,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
inclusion body assembly,GO:0070841,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
indole metabolic process,GO:0042431,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
inflammasome complex assembly,GO:0140632,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
inflammatory cell apoptotic process,GO:0006925,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,FAS
inflammatory cell apoptotic process,GO:0006925,Lupus Nephritis,MESH:D008181,0,,2,FAS|IFNG
inflammatory response,GO:0006954,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
inflammatory response,GO:0006954,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Prednisone|Quinacrine|Valproic Acid,0,
inflammatory response,GO:0006954,"Lupus Erythematosus, Systemic",MESH:D008180,20,Amiodarone|Aspirin|Celecoxib|Diclofenac|Estradiol|Indomethacin|Isoniazid|Melatonin|Methotrexate|Methylprednisolone|Minocycline|Particulate Matter|Prednisone|Propylthiouracil|Quinacrine|Silicon Dioxide|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vincristine,13,CD40LG|CR2|CRP|FCGR2B|IL6|IRF5|NCF1|PXK|TLR5|TNFAIP3|TNFSF4|TNIP1|TREX1
inflammatory response,GO:0006954,Lupus Nephritis,MESH:D008181,7,Dexamethasone|Isoniazid|Lipopolysaccharides|Methylprednisolone|Prednisone|Propylthiouracil|Rutin,1,C3
inflammatory response,GO:0006954,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Prednisone,0,
inflammatory response to antigenic stimulus,GO:0002437,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
inflammatory response to antigenic stimulus,GO:0002437,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,3,HLA-DRB1|RASGRP1|TREX1
inflammatory response to antigenic stimulus,GO:0002437,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
inflammatory response to wounding,GO:0090594,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
inflammatory response to wounding,GO:0090594,Lupus Nephritis,MESH:D008181,0,,1,MMP9
inhibitory postsynaptic potential,GO:0060080,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chlorpromazine|Cocaine|Metoprolol,0,
initiation of primordial ovarian follicle growth,GO:0001544,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
initiation of primordial ovarian follicle growth,GO:0001544,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
innate immune response,GO:0045087,Chilblain lupus 1,MESH:C535924,0,,3,SAMHD1|STING1|TREX1
innate immune response,GO:0045087,CHILBLAIN LUPUS 2,OMIM:614415,0,,1,SAMHD1
innate immune response,GO:0045087,"Lupus Erythematosus, Systemic",MESH:D008180,2,Tobacco Smoke Pollution|tofacitinib,16,BLK|C1QA|CFB|CLU|CR2|CRP|IFIH1|IRAK4|IRF5|ITGAM|NCF1|PRDM1|SLC15A4|TLR5|TNFSF4|TREX1
innate immune response,GO:0045087,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,2,C3|SERPING1
innate immune response,GO:0045087,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
innate immune response in mucosa,GO:0002227,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL4
innervation,GO:0060384,Lupus Nephritis,MESH:D008181,0,,1,C3
inorganic cation transmembrane transport,GO:0098662,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
inosine metabolic process,GO:0046102,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
inositol metabolic process,GO:0006020,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
insulin metabolic process,GO:1901142,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Propylthiouracil,0,
insulin metabolic process,GO:1901142,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
integrin-mediated signaling pathway,GO:0007229,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,CD40LG|ITGAM
integrin-mediated signaling pathway,GO:0007229,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
interferon-alpha production,GO:0032607,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
interferon-alpha production,GO:0032607,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
interferon-beta production,GO:0032608,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IFIH1
interleukin-10-mediated signaling pathway,GO:0140105,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL10
interleukin-10-mediated signaling pathway,GO:0140105,Lupus Nephritis,MESH:D008181,0,,1,JAK1
interleukin-10 production,GO:0032613,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,2,FCGR2B|IL21
interleukin-10 production,GO:0032613,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
interleukin-11-mediated signaling pathway,GO:0038154,Lupus Nephritis,MESH:D008181,0,,1,JAK1
interleukin-12-mediated signaling pathway,GO:0035722,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IL12B|STAT4
interleukin-12 production,GO:0032615,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,1,IFNG
interleukin-15-mediated signaling pathway,GO:0035723,Lupus Nephritis,MESH:D008181,0,,1,JAK1
interleukin-17 production,GO:0032620,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
interleukin-1 beta production,GO:0032611,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
interleukin-1-mediated signaling pathway,GO:0070498,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IRAK4
interleukin-1 production,GO:0032612,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
interleukin-1 production,GO:0032612,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
interleukin-21-mediated signaling pathway,GO:0038114,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL21R
interleukin-23-mediated signaling pathway,GO:0038155,"Lupus Erythematosus, Systemic",MESH:D008180,1,tofacitinib,0,
interleukin-23 production,GO:0032627,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
interleukin-27-mediated signaling pathway,GO:0070106,Lupus Nephritis,MESH:D008181,0,,1,STAT1
interleukin-27 production,GO:0032631,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
interleukin-2-mediated signaling pathway,GO:0038110,Lupus Nephritis,MESH:D008181,0,,1,JAK1
interleukin-2 production,GO:0032623,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
interleukin-33-mediated signaling pathway,GO:0038172,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IRAK4
interleukin-4-mediated signaling pathway,GO:0035771,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL4
interleukin-4-mediated signaling pathway,GO:0035771,Lupus Nephritis,MESH:D008181,0,,1,JAK1
interleukin-5 production,GO:0032634,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
interleukin-6-mediated signaling pathway,GO:0070102,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
interleukin-6-mediated signaling pathway,GO:0070102,Lupus Nephritis,MESH:D008181,0,,1,JAK1
interleukin-6 production,GO:0032635,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Hydroxychloroquine,0,
interleukin-6 production,GO:0032635,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Hydroxychloroquine,0,
interleukin-6 production,GO:0032635,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Hydroxychloroquine,1,BANK1
interleukin-6 production,GO:0032635,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
interleukin-7-mediated signaling pathway,GO:0038111,Lupus Nephritis,MESH:D008181,0,,2,JAK1|STAT1
interleukin-9-mediated signaling pathway,GO:0038113,Lupus Nephritis,MESH:D008181,0,,2,JAK1|STAT1
inter-male aggressive behavior,GO:0002121,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
intestinal epithelial cell development,GO:0060576,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Vitamin B 12,1,PRDM1
intestinal epithelial structure maintenance,GO:0060729,"Lupus Erythematosus, Systemic",MESH:D008180,1,Sulfasalazine,1,TERT
intestinal epithelial structure maintenance,GO:0060729,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
intestinal stem cell homeostasis,GO:0036335,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CAT
intracellular distribution of mitochondria,GO:0048312,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Lupus Erythematosus, Systemic",MESH:D008180,2,Valproic Acid|Vincristine,1,CLU
intracellular estrogen receptor signaling pathway,GO:0030520,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
intracellular estrogen receptor signaling pathway,GO:0030520,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
intracellular pH elevation,GO:0051454,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
intracellular pH elevation,GO:0051454,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
intracellular pH elevation,GO:0051454,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
intracellular pH reduction,GO:0051452,"Lupus Erythematosus, Systemic",MESH:D008180,1,chloroquine diphosphate,0,
intracellular signal transduction,GO:0035556,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,BLK|CSK|SH2B3
intracellular signal transduction,GO:0035556,Lupus Nephritis,MESH:D008181,0,,1,JAK1
intracellular transport of virus,GO:0075733,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Hydroxychloroquine,0,
intracellular transport of virus,GO:0075733,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Hydroxychloroquine,0,
intracellular transport of virus,GO:0075733,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Hydroxychloroquine,0,
intramembranous ossification,GO:0001957,Lupus Nephritis,MESH:D008181,0,,1,MMP2
intrinsic apoptotic signaling pathway,GO:0097193,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Sertraline,0,
intrinsic apoptotic signaling pathway,GO:0097193,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CLU
in utero embryonic development,GO:0001701,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRDM1
iron ion export across plasma membrane,GO:1903988,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
iron ion export across plasma membrane,GO:1903988,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
iron ion export across plasma membrane,GO:1903988,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
iron ion homeostasis,GO:0055072,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Rifampin|Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
iron ion homeostasis,GO:0055072,"Lupus Erythematosus, Systemic",MESH:D008180,7,Chloroquine|Cyclophosphamide|Folic Acid|Isoniazid|Rifampin|Tobacco Smoke Pollution|Valproic Acid,0,
iron ion homeostasis,GO:0055072,Lupus Nephritis,MESH:D008181,4,Cyclophosphamide|Isoniazid|Lipopolysaccharides|Rifampin,0,
iron ion homeostasis,GO:0055072,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
isotype switching,GO:0045190,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CD40LG
isotype switching to IgE isotypes,GO:0048289,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL4
isotype switching to IgG isotypes,GO:0048291,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL4
JNK cascade,GO:0007254,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Sertraline,0,
JNK cascade,GO:0007254,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IRAK4
JUN phosphorylation,GO:0007258,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
keratinization,GO:0031424,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
keratinocyte activation,GO:0032980,"Lupus Erythematosus, Systemic",MESH:D008180,1,tofacitinib,0,
keratinocyte differentiation,GO:0030216,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTGS2
kidney development,GO:0001822,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
kidney development,GO:0001822,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,CAT|PRDM1|TREX1
kidney development,GO:0001822,Lupus Nephritis,MESH:D008181,0,,1,MMP9
kinesis,GO:0042465,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
kynurenic acid biosynthetic process,GO:0034276,"Lupus Erythematosus, Systemic",MESH:D008180,1,Propylthiouracil,0,
kynurenic acid biosynthetic process,GO:0034276,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
kynurenic acid metabolic process,GO:0034275,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
lactate biosynthetic process,GO:0019249,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Rifampin,0,
lactate biosynthetic process,GO:0019249,"Lupus Erythematosus, Systemic",MESH:D008180,6,Chlorpromazine|Folic Acid|Isoniazid|Particulate Matter|Rifampin|triptolide,0,
lactate biosynthetic process,GO:0019249,Lupus Nephritis,MESH:D008181,2,Isoniazid|Rifampin,0,
lactate metabolic process,GO:0006089,"Lupus Erythematosus, Systemic",MESH:D008180,3,Cyclophosphamide|Particulate Matter|Tobacco Smoke Pollution,0,
lactate metabolic process,GO:0006089,Lupus Nephritis,MESH:D008181,4,Cyclophosphamide|Lipopolysaccharides|Niclosamide|Rutin,0,
lactate metabolic process,GO:0006089,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
lactation,GO:0007595,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,1,PRL
lactic acid secretion,GO:0046722,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
lactose metabolic process,GO:0005988,"Lupus Erythematosus, Systemic",MESH:D008180,1,Diclofenac,0,
"L-alanine catabolic process, by transamination",GO:0019481,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
"L-alanine catabolic process, by transamination",GO:0019481,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
"L-alanine catabolic process, by transamination",GO:0019481,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
lamellipodium assembly,GO:0030032,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,1,P2RY12
larval development,GO:0002164,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
larval development,GO:0002164,"Lupus Erythematosus, Systemic",MESH:D008180,4,Estradiol|Methotrexate|Particulate Matter|Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Lupus Erythematosus, Systemic",MESH:D008180,3,Minocycline|Particulate Matter|Valproic Acid,0,
larval somatic muscle development,GO:0007526,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CRP
L-ascorbic acid metabolic process,GO:0019852,"Lupus Erythematosus, Systemic",MESH:D008180,2,Indomethacin|Vincristine,0,
lateral inhibition,GO:0046331,Lupus Nephritis,MESH:D008181,0,,1,MMP2
learning,GO:0007612,"Lupus Erythematosus, Systemic",MESH:D008180,4,Folic Acid|Minocycline|Particulate Matter|Propylthiouracil,1,PTGS2
learning,GO:0007612,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Propylthiouracil,0,
learning or memory,GO:0007611,"Lupus Erythematosus, Systemic",MESH:D008180,3,Minocycline|Particulate Matter|Propylthiouracil,0,
learning or memory,GO:0007611,Lupus Nephritis,MESH:D008181,1,Propylthiouracil,0,
leukocyte activation,GO:0045321,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
leukocyte adhesion to vascular endothelial cell,GO:0061756,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,ITGAM
leukocyte adhesion to vascular endothelial cell,GO:0061756,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
leukocyte adhesion to vascular endothelial cell,GO:0061756,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
leukocyte adhesive activation,GO:0050902,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
leukocyte cell-cell adhesion,GO:0007159,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,CD40LG|ITGAM|TNIP1
leukocyte cell-cell adhesion,GO:0007159,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
leukocyte cell-cell adhesion,GO:0007159,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
leukocyte chemotaxis,GO:0030595,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Dapsone|Prednisolone|Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Lupus Erythematosus, Systemic",MESH:D008180,13,Aspirin|Celecoxib|Chlorpromazine|Diclofenac|Griseofulvin|Homocysteine|Indomethacin|Methylprednisolone|Minocycline|Prednisolone|Rifampin|Tobacco Smoke Pollution|Vincristine,1,IL10
leukocyte chemotaxis,GO:0030595,Lupus Nephritis,MESH:D008181,5,Lipopolysaccharides|Methylprednisolone|Pentoxifylline|Prednisolone|Rifampin,0,
leukocyte chemotaxis involved in inflammatory response,GO:0002232,"Lupus Erythematosus, Systemic",MESH:D008180,5,Celecoxib|Diclofenac|Indomethacin|Silicon Dioxide|Sulfasalazine,0,
leukocyte chemotaxis involved in inflammatory response,GO:0002232,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
leukocyte degranulation,GO:0043299,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,pimecrolimus|Thalidomide,0,
leukocyte degranulation,GO:0043299,"Lupus Erythematosus, Discoid",MESH:D008179,1,Thalidomide,0,
leukocyte degranulation,GO:0043299,"Lupus Erythematosus, Systemic",MESH:D008180,3,Sulfasalazine|Tacrolimus|Thalidomide,0,
leukocyte degranulation,GO:0043299,Lupus Nephritis,MESH:D008181,5,Dexamethasone|Heparin|Lipopolysaccharides|Pentoxifylline|Tacrolimus,0,
leukocyte degranulation,GO:0043299,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
leukocyte homeostasis,GO:0001776,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
leukocyte homeostasis,GO:0001776,"Lupus Erythematosus, Systemic",MESH:D008180,4,Ibuprofen|Indomethacin|Particulate Matter|Tobacco Smoke Pollution,0,
leukocyte homeostasis,GO:0001776,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Rutin,0,
leukocyte mediated cytotoxicity,GO:0001909,"Lupus Erythematosus, Systemic",MESH:D008180,2,Mycophenolic Acid|Tacrolimus,1,NCF1
leukocyte mediated cytotoxicity,GO:0001909,Lupus Nephritis,MESH:D008181,2,Mycophenolic Acid|Tacrolimus,0,
leukocyte migration,GO:0050900,"Lupus Erythematosus, Systemic",MESH:D008180,3,Particulate Matter|Silicon Dioxide|Tobacco Smoke Pollution,0,
leukocyte migration,GO:0050900,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
leukocyte migration involved in immune response,GO:0002522,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Particulate Matter,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Lupus Erythematosus, Cutaneous",MESH:D008178,4,Fluorouracil|Prednisolone|Rifampin|Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Lupus Erythematosus, Systemic",MESH:D008180,18,Amiodarone|Aspirin|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Indomethacin|Melatonin|Methotrexate|Particulate Matter|Prednisolone|Rifampin|Silicon Dioxide|Sulfasalazine|Tobacco Smoke Pollution|tofacitinib|triptolide|Valproic Acid,1,ITGAM
leukocyte migration involved in inflammatory response,GO:0002523,Lupus Nephritis,MESH:D008181,7,arsenic disulfide|Cyclophosphamide|Dexamethasone|Lipopolysaccharides|Prednisolone|Rifampin|Rutin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,1,ITGAM
leukocyte proliferation,GO:0070661,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
leukocyte proliferation,GO:0070661,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,STAT4
leukocyte proliferation,GO:0070661,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
leukocyte tethering or rolling,GO:0050901,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Thalidomide,0,
leukocyte tethering or rolling,GO:0050901,"Lupus Erythematosus, Discoid",MESH:D008179,1,Thalidomide,0,
leukocyte tethering or rolling,GO:0050901,"Lupus Erythematosus, Systemic",MESH:D008180,6,Celecoxib|Diclofenac|Indomethacin|Melatonin|Tacrolimus|Thalidomide,0,
leukocyte tethering or rolling,GO:0050901,Lupus Nephritis,MESH:D008181,4,Dexamethasone|Heparin|Lipopolysaccharides|Tacrolimus,0,
leukocyte tethering or rolling,GO:0050901,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
leukotriene B4 biosynthetic process,GO:0097251,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
leukotriene metabolic process,GO:0006691,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,NCF1
leukotriene production involved in inflammatory response,GO:0002540,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
leukotriene transport,GO:0071716,"Lupus Erythematosus, Systemic",MESH:D008180,1,Celecoxib,0,
Leydig cell differentiation,GO:0033327,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
L-glutamate import,GO:0051938,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
L-glutamate import,GO:0051938,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,0,
L-histidine transmembrane export from vacuole,GO:0089708,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SLC15A4
limb development,GO:0060173,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
lipid biosynthetic process,GO:0008610,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Fluorouracil|Rifampin|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Lupus Erythematosus, Discoid",MESH:D008179,1,Azathioprine,0,
lipid biosynthetic process,GO:0008610,"Lupus Erythematosus, Systemic",MESH:D008180,11,Amiodarone|Aspirin|Azathioprine|Chlorpromazine|Estradiol|Indomethacin|Isoniazid|Methotrexate|Rifampin|Triglycerides|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,Lupus Nephritis,MESH:D008181,4,Azathioprine|Dexamethasone|Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Azathioprine,0,
lipid catabolic process,GO:0016042,"Lupus Erythematosus, Cutaneous",MESH:D008178,6,Chloroquine|Fluorouracil|Prednisolone|Quinacrine|Rifampin|Valproic Acid,0,
lipid catabolic process,GO:0016042,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
lipid catabolic process,GO:0016042,"Lupus Erythematosus, Systemic",MESH:D008180,32,Amiodarone|Aspirin|Celecoxib|Chloroquine|chloroquine diphosphate|Cocaine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Griseofulvin|Homocysteine|Indomethacin|Isoniazid|Melatonin|Methotrexate|Minocycline|Particulate Matter|Penicillamine|Prednisolone|Propylthiouracil|Quinacrine|Quinidine|Ranitidine|Rifampin|Silicon Dioxide|Sulfasalazine|Thiobarbituric Acid Reactive Substances|Tobacco Smoke Pollution|Triglycerides|triptolide|Valproic Acid,0,
lipid catabolic process,GO:0016042,Lupus Nephritis,MESH:D008181,12,arsenic disulfide|Cyclophosphamide|Dexamethasone|Heparin|Isoniazid|Lipopolysaccharides|Pentoxifylline|Prednisolone|Propylthiouracil|Quinidine|Rifampin|Rutin,0,
lipid catabolic process,GO:0016042,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
lipid droplet formation,GO:0140042,"Lupus Erythematosus, Cutaneous",MESH:D008178,4,Chloroquine|Prednisolone|Rifampin|Valproic Acid,0,
lipid droplet formation,GO:0140042,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
lipid droplet formation,GO:0140042,"Lupus Erythematosus, Systemic",MESH:D008180,16,Amiodarone|Chloroquine|Estradiol|Folic Acid|Hydralazine|Indomethacin|Isoniazid|Melatonin|Methotrexate|Particulate Matter|Prednisolone|Rifampin|Tacrolimus|Triglycerides|triptolide|Valproic Acid,0,
lipid droplet formation,GO:0140042,Lupus Nephritis,MESH:D008181,7,Dexamethasone|Isoniazid|Lipopolysaccharides|Prednisolone|Rifampin|Rutin|Tacrolimus,0,
lipid droplet organization,GO:0034389,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
lipid homeostasis,GO:0055088,"Lupus Erythematosus, Systemic",MESH:D008180,3,"Cholesterol, VLDL|Tobacco Smoke Pollution|Triglycerides",0,
lipid import into cell,GO:0140354,"Lupus Erythematosus, Systemic",MESH:D008180,1,Triglycerides,0,
lipid import into cell,GO:0140354,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
lipid localization,GO:0010876,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Homocysteine,0,
lipid metabolic process,GO:0006629,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Prednisone|Valproic Acid,0,
lipid metabolic process,GO:0006629,"Lupus Erythematosus, Discoid",MESH:D008179,1,Azathioprine,0,
lipid metabolic process,GO:0006629,"Lupus Erythematosus, Systemic",MESH:D008180,13,"Amiodarone|Azathioprine|Chlorpromazine|Cholesterol, VLDL|Folic Acid|Isoniazid|Methotrexate|Particulate Matter|Prednisone|Silicon Dioxide|Tobacco Smoke Pollution|Triglycerides|Valproic Acid",3,CLU|JAZF1|PTPN22
lipid metabolic process,GO:0006629,Lupus Nephritis,MESH:D008181,4,Azathioprine|Dexamethasone|Isoniazid|Prednisone,0,
lipid metabolic process,GO:0006629,"Panniculitis, Lupus Erythematosus",MESH:D015435,2,Azathioprine|Prednisone,0,
lipid oxidation,GO:0034440,"Lupus Erythematosus, Cutaneous",MESH:D008178,6,Chloroquine|Fluorouracil|Prednisolone|Rifampin|Thalidomide|Valproic Acid,0,
lipid oxidation,GO:0034440,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Thalidomide,0,
lipid oxidation,GO:0034440,"Lupus Erythematosus, Systemic",MESH:D008180,26,Aspirin|Carbamazepine|Celecoxib|Chloroquine|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Ibuprofen|Indomethacin|Isoniazid|Melatonin|Methotrexate|Methylprednisolone|Particulate Matter|Prednisolone|Rifampin|Silicon Dioxide|Sulfasalazine|Thalidomide|Thiobarbituric Acid Reactive Substances|Tobacco Smoke Pollution|triptolide|Valproic Acid|Vincristine|Vitamin B 12,0,
lipid oxidation,GO:0034440,Lupus Nephritis,MESH:D008181,10,arsenic disulfide|Cyclophosphamide|Dexamethasone|Isoniazid|Lipopolysaccharides|Methylprednisolone|Pentoxifylline|Prednisolone|Rifampin|Rutin,0,
lipid oxidation,GO:0034440,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
lipid oxidation,GO:0034440,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
lipid storage,GO:0019915,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
lipid storage,GO:0019915,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
lipopolysaccharide biosynthetic process,GO:0009103,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
lipopolysaccharide-mediated signaling pathway,GO:0031663,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTPN22
lipopolysaccharide-mediated signaling pathway,GO:0031663,Lupus Nephritis,MESH:D008181,0,,1,STAT1
lipopolysaccharide metabolic process,GO:0008653,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Rutin,0,
lipopolysaccharide transport,GO:0015920,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
lipoprotein biosynthetic process,GO:0042158,"Lupus Erythematosus, Systemic",MESH:D008180,1,Amiodarone,0,
lipoprotein metabolic process,GO:0042157,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
lipoprotein oxidation,GO:0042161,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
lipoprotein oxidation,GO:0042161,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
lipoxin A4 biosynthetic process,GO:2001303,"Lupus Erythematosus, Systemic",MESH:D008180,2,Aspirin|Celecoxib,0,
lipoxygenase pathway,GO:0019372,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,1,PTGS2
liver development,GO:0001889,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Prednisone,0,
liver development,GO:0001889,"Lupus Erythematosus, Systemic",MESH:D008180,3,Carbamazepine|Estradiol|Prednisone,0,
liver development,GO:0001889,Lupus Nephritis,MESH:D008181,1,Prednisone,0,
liver development,GO:0001889,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Prednisone,0,
liver morphogenesis,GO:0072576,"Lupus Erythematosus, Systemic",MESH:D008180,1,triptolide,0,
liver regeneration,GO:0097421,"Lupus Erythematosus, Systemic",MESH:D008180,0,,3,FAS|IL10|IL6
liver regeneration,GO:0097421,Lupus Nephritis,MESH:D008181,0,,1,FAS
locomotion,GO:0040011,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
locomotion involved in locomotory behavior,GO:0031987,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
locomotion involved in locomotory behavior,GO:0031987,"Lupus Erythematosus, Systemic",MESH:D008180,11,Chloroquine|chloroquine diphosphate|Cocaine|Indomethacin|Isoniazid|Minocycline|Particulate Matter|Penicillamine|Propylthiouracil|Tacrolimus|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,Lupus Nephritis,MESH:D008181,6,Dexamethasone|Isoniazid|Lipopolysaccharides|Methimazole|Propylthiouracil|Tacrolimus,0,
locomotory behavior,GO:0007626,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Prednisolone|Valproic Acid,0,
locomotory behavior,GO:0007626,"Lupus Erythematosus, Systemic",MESH:D008180,5,Cocaine|Particulate Matter|Prednisolone|Silicon Dioxide|Valproic Acid,0,
locomotory behavior,GO:0007626,Lupus Nephritis,MESH:D008181,1,Prednisolone,0,
locomotory exploration behavior,GO:0035641,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Particulate Matter,0,
long-chain fatty acid biosynthetic process,GO:0042759,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PTGS2
long-term memory,GO:0007616,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Fluorouracil,0,
long-term memory,GO:0007616,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Methotrexate,0,
long-term memory,GO:0007616,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
long-term memory,GO:0007616,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
low-density lipoprotein particle remodeling,GO:0034374,Lupus Nephritis,MESH:D008181,1,Rutin,0,
L-phenylalanine metabolic process,GO:0006558,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
lung alveolus development,GO:0048286,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
lung development,GO:0030324,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
lung development,GO:0030324,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
lung goblet cell differentiation,GO:0060480,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
lung goblet cell differentiation,GO:0060480,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
luteinization,GO:0001553,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
luteinization,GO:0001553,Lupus Nephritis,MESH:D008181,0,,1,MMP2
luteinizing hormone secretion,GO:0032275,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
lymph node development,GO:0048535,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IKZF1
lymphocyte activation,GO:0046649,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Thalidomide,0,
lymphocyte activation,GO:0046649,"Lupus Erythematosus, Discoid",MESH:D008179,1,Thalidomide,0,
lymphocyte activation,GO:0046649,"Lupus Erythematosus, Systemic",MESH:D008180,3,Mycophenolic Acid|Tacrolimus|Thalidomide,0,
lymphocyte activation,GO:0046649,Lupus Nephritis,MESH:D008181,4,Lipopolysaccharides|Mycophenolic Acid|Pentoxifylline|Tacrolimus,0,
lymphocyte activation,GO:0046649,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
lymphocyte activation involved in immune response,GO:0002285,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
lymphocyte apoptotic process,GO:0070227,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FAS
lymphocyte apoptotic process,GO:0070227,Lupus Nephritis,MESH:D008181,0,,1,FAS
lymphocyte chemotaxis,GO:0048247,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Tobacco Smoke Pollution,0,
lymphocyte costimulation,GO:0031294,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL6
lymphocyte differentiation,GO:0030098,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IKZF1
lymphocyte homeostasis,GO:0002260,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cyclophosphamide|Particulate Matter,0,
lymphocyte homeostasis,GO:0002260,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Lipopolysaccharides,0,
lymphocyte homeostasis,GO:0002260,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
lymphocyte mediated immunity,GO:0002449,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
lymphocyte mediated immunity,GO:0002449,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
lymphocyte mediated immunity,GO:0002449,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
lymphocyte migration,GO:0072676,"Lupus Erythematosus, Systemic",MESH:D008180,4,Amiodarone|Particulate Matter|Silicon Dioxide|Tobacco Smoke Pollution,0,
lymphocyte migration,GO:0072676,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
lymphocyte proliferation,GO:0046651,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
lymphocyte proliferation,GO:0046651,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
lymphoid progenitor cell differentiation,GO:0002320,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
lymphoid progenitor cell differentiation,GO:0002320,"Lupus Erythematosus, Systemic",MESH:D008180,0,,2,IKZF1|TREX1
lymph vessel development,GO:0001945,Lupus Nephritis,MESH:D008181,0,,1,MMP2
lysosomal lumen acidification,GO:0007042,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
lysosomal lumen acidification,GO:0007042,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
lysosomal lumen acidification,GO:0007042,"Lupus Erythematosus, Systemic",MESH:D008180,2,Chloroquine|Particulate Matter,0,
lysosomal lumen pH elevation,GO:0035752,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
lysosomal lumen pH elevation,GO:0035752,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chloroquine|Rifampin|Silicon Dioxide,0,
lysosomal lumen pH elevation,GO:0035752,Lupus Nephritis,MESH:D008181,1,Rifampin,0,
lysosomal membrane organization,GO:0097212,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
lysosomal membrane organization,GO:0097212,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
lysosomal membrane organization,GO:0097212,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chloroquine|Ibuprofen|Silicon Dioxide,0,
lysosomal protein catabolic process,GO:1905146,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
lysosomal protein catabolic process,GO:1905146,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
lysosomal protein catabolic process,GO:1905146,"Lupus Erythematosus, Systemic",MESH:D008180,2,Amiodarone|Chloroquine,0,
lysosomal transport,GO:0007041,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
lysosomal transport,GO:0007041,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
lysosomal transport,GO:0007041,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chloroquine,0,
lysosome organization,GO:0007040,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
lysosome organization,GO:0007040,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
lysosome organization,GO:0007040,"Lupus Erythematosus, Systemic",MESH:D008180,3,Amiodarone|Chloroquine|chloroquine diphosphate,0,
lysosome organization,GO:0007040,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
macrophage activation,GO:0042116,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
macrophage activation,GO:0042116,"Lupus Erythematosus, Systemic",MESH:D008180,7,Amiodarone|Celecoxib|Cocaine|Minocycline|Particulate Matter|Sulfasalazine|Valproic Acid,1,IL4
macrophage activation,GO:0042116,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
macrophage activation,GO:0042116,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,FCGR3A
macrophage activation involved in immune response,GO:0002281,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
macrophage activation involved in immune response,GO:0002281,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Tobacco Smoke Pollution,1,TREX1
macrophage activation involved in immune response,GO:0002281,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,1,IFNG
macrophage chemotaxis,GO:0048246,Lupus Nephritis,MESH:D008181,0,,2,MMP2|MMP9
macrophage cytokine production,GO:0010934,Lupus Nephritis,MESH:D008181,0,,1,IFNG
macrophage derived foam cell differentiation,GO:0010742,Lupus Nephritis,MESH:D008181,0,,1,STAT1
macrophage differentiation,GO:0030225,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,2,HLA-DRB1|IL6
macrophage differentiation,GO:0030225,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,2,IFNG|MMP9
macrophage homeostasis,GO:0061519,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
macrophage migration,GO:1905517,"Lupus Erythematosus, Systemic",MESH:D008180,6,Amiodarone|Isoniazid|Methotrexate|Particulate Matter|Silicon Dioxide|Tobacco Smoke Pollution,0,
macrophage migration,GO:1905517,Lupus Nephritis,MESH:D008181,3,Dexamethasone|Isoniazid|Lipopolysaccharides,0,
macrophage proliferation,GO:0061517,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
macrophage proliferation,GO:0061517,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
maintenance of blood-brain barrier,GO:0035633,"Lupus Erythematosus, Systemic",MESH:D008180,2,Melatonin|Particulate Matter,2,IL6|PTGS2
maintenance of blood-brain barrier,GO:0035633,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
maintenance of gastrointestinal epithelium,GO:0030277,"Lupus Erythematosus, Systemic",MESH:D008180,1,Diclofenac,0,
maintenance of location,GO:0051235,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
maintenance of protein localization in organelle,GO:0072595,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Hydroxychloroquine,0,
maintenance of protein localization in organelle,GO:0072595,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
maintenance of protein localization in organelle,GO:0072595,"Lupus Erythematosus, Systemic",MESH:D008180,1,Hydroxychloroquine,0,
maintenance of protein location in nucleus,GO:0051457,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
maintenance of rDNA,GO:0043007,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,CLEC16A
male gonad development,GO:0008584,"Lupus Erythematosus, Systemic",MESH:D008180,3,Estradiol|Propylthiouracil|triptolide,1,TLR5
male gonad development,GO:0008584,Lupus Nephritis,MESH:D008181,2,Diethylstilbestrol|Propylthiouracil,0,
male meiosis I,GO:0007141,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
mammary gland development,GO:0030879,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,PRL
mammary gland duct morphogenesis,GO:0060603,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
mammary gland epithelial cell differentiation,GO:0060644,Lupus Nephritis,MESH:D008181,1,Dexamethasone,0,
mammary gland epithelial cell proliferation,GO:0033598,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
manganese ion transmembrane transport,GO:0071421,"Lupus Erythematosus, Systemic",MESH:D008180,1,Quinidine,0,
manganese ion transmembrane transport,GO:0071421,Lupus Nephritis,MESH:D008181,2,Diethylstilbestrol|Quinidine,0,
MAPK cascade,GO:0000165,"Lupus Erythematosus, Systemic",MESH:D008180,5,Cocaine|Estradiol|Minocycline|Mycophenolic Acid|Tacrolimus,2,BANK1|RASGRP3
MAPK cascade,GO:0000165,Lupus Nephritis,MESH:D008181,5,Dexamethasone|Lipopolysaccharides|Mycophenolic Acid|Pentoxifylline|Tacrolimus,0,
marginal zone B cell differentiation,GO:0002315,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNFAIP3
mast cell activation,GO:0045576,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2A
mast cell cytokine production,GO:0032762,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,RASGRP1
mast cell degranulation,GO:0043303,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlorpromazine,1,RASGRP1
mast cell degranulation,GO:0043303,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
mast cell homeostasis,GO:0033023,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SLC15A4
mast cell migration,GO:0097531,"Lupus Erythematosus, Systemic",MESH:D008180,1,Silicon Dioxide,0,
maternal behavior,GO:0042711,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,PRL
maternal placenta development,GO:0001893,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,1,PRDM1
maternal process involved in female pregnancy,GO:0060135,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Lupus Erythematosus, Systemic",MESH:D008180,1,Valproic Acid,1,FAS
maternal process involved in female pregnancy,GO:0060135,Lupus Nephritis,MESH:D008181,0,,1,FAS
mature B cell differentiation involved in immune response,GO:0002313,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,FCGR2B
mature conventional dendritic cell differentiation,GO:0097029,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
MDA-5 signaling pathway,GO:0039530,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IFIH1
megakaryocyte development,GO:0035855,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,SH2B3
meiosis I,GO:0007127,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
meiosis I cell cycle process,GO:0061982,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
meiosis I cytokinesis,GO:0007110,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
meiotic anaphase I,GO:0007133,Lupus Nephritis,MESH:D008181,1,Diethylstilbestrol,0,
meiotic cell cycle,GO:0051321,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlordecone,0,
meiotic cell cycle checkpoint signaling,GO:0033313,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Lupus Erythematosus, Systemic",MESH:D008180,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
meiotic DNA double-strand break formation,GO:0042138,"Lupus Erythematosus, Systemic",MESH:D008180,1,Estradiol,0,
meiotic DNA repair synthesis,GO:0000711,"Lupus Erythematosus, Systemic",MESH:D008180,1,Chlordecone,0,
meiotic metaphase II,GO:0007137,"Lupus Erythematosus, Systemic",MESH:D008180,1,Cyclophosphamide,0,
meiotic metaphase II,GO:0007137,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Diethylstilbestrol,0,
meiotic metaphase II,GO:0007137,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
meiotic metaphase plate congression,GO:0051311,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
meiotic spindle organization,GO:0000212,"Lupus Erythematosus, Systemic",MESH:D008180,2,Isoniazid|Melatonin,0,
meiotic spindle organization,GO:0000212,Lupus Nephritis,MESH:D008181,1,Isoniazid,0,
melanin biosynthetic process,GO:0042438,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
melatonin biosynthetic process,GO:0030187,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
melatonin metabolic process,GO:0030186,"Lupus Erythematosus, Systemic",MESH:D008180,1,Melatonin,0,
membrane depolarization,GO:0051899,"Lupus Erythematosus, Systemic",MESH:D008180,5,Cyclophosphamide|Diclofenac|Homocysteine|Melatonin|Particulate Matter,0,
membrane depolarization,GO:0051899,Lupus Nephritis,MESH:D008181,2,Cyclophosphamide|Lipopolysaccharides,0,
membrane depolarization,GO:0051899,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
membrane disassembly,GO:0030397,"Lupus Erythematosus, Systemic",MESH:D008180,2,Particulate Matter|Silicon Dioxide,0,
membrane lipid catabolic process,GO:0046466,"Lupus Erythematosus, Cutaneous",MESH:D008178,7,Cinnarizine|Fluorouracil|Nitrendipine|Quinacrine|Rifampin|Thalidomide|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Lupus Erythematosus, Discoid",MESH:D008179,1,Thalidomide,0,
membrane lipid catabolic process,GO:0046466,"Lupus Erythematosus, Systemic",MESH:D008180,27,Amiodarone|Aspirin|Celecoxib|chloroquine diphosphate|Chlorpromazine|Cocaine|Cyclophosphamide|Diclofenac|Estradiol|Ibuprofen|Indomethacin|Isoniazid|Melatonin|Methylprednisolone|Metoprolol|Particulate Matter|Penicillamine|Propylthiouracil|Quinacrine|Quinidine|Rifampin|Silicon Dioxide|Tacrolimus|Thalidomide|Thiobarbituric Acid Reactive Substances|Tobacco Smoke Pollution|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,Lupus Nephritis,MESH:D008181,13,Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Heparin|Isoniazid|Lipopolysaccharides|Methylprednisolone|Pentoxifylline|Propylthiouracil|Quinidine|Rifampin|Rutin|Tacrolimus,0,
membrane lipid catabolic process,GO:0046466,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
membrane lipid catabolic process,GO:0046466,"Panniculitis, Lupus Erythematosus",MESH:D015435,1,Thalidomide,0,
membrane organization,GO:0061024,"Lupus Erythematosus, Cutaneous",MESH:D008178,2,Chloroquine|Rifampin,0,
membrane organization,GO:0061024,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
membrane organization,GO:0061024,"Lupus Erythematosus, Systemic",MESH:D008180,4,Chloroquine|Indomethacin|Particulate Matter|Rifampin,0,
membrane organization,GO:0061024,Lupus Nephritis,MESH:D008181,2,Methimazole|Rifampin,0,
membrane raft organization,GO:0031579,"Lupus Erythematosus, Systemic",MESH:D008180,1,Triglycerides,0,
membrane repolarization,GO:0086009,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Hydroxychloroquine,0,
membrane repolarization,GO:0086009,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
membrane repolarization,GO:0086009,"Lupus Erythematosus, Systemic",MESH:D008180,1,Hydroxychloroquine,0,
membrane tubulation,GO:0097749,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
memory,GO:0007613,"Lupus Erythematosus, Systemic",MESH:D008180,10,Aspirin|Cyclophosphamide|Estradiol|Folic Acid|Ibuprofen|Melatonin|Minocycline|Particulate Matter|Propylthiouracil|Tobacco Smoke Pollution,1,PTGS2
memory,GO:0007613,Lupus Nephritis,MESH:D008181,4,Cyclophosphamide|Dexamethasone|Lipopolysaccharides|Propylthiouracil,0,
memory,GO:0007613,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
memory T cell activation,GO:0035709,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TNFSF4
memory T cell proliferation,GO:0061485,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
menopause,GO:0042697,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
mesoderm development,GO:0007498,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IKZF1
metabolic process,GO:0008152,"Lupus Erythematosus, Systemic",MESH:D008180,2,Estradiol|Tobacco Smoke Pollution,0,
metabolic process,GO:0008152,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
metal ion homeostasis,GO:0055065,"Lupus Erythematosus, Systemic",MESH:D008180,1,Tobacco Smoke Pollution,0,
metamorphosis,GO:0007552,"Lupus Erythematosus, Systemic",MESH:D008180,2,Amiodarone|Propylthiouracil,0,
metamorphosis,GO:0007552,Lupus Nephritis,MESH:D008181,2,Methimazole|Propylthiouracil,0,
metanephric mesenchymal cell differentiation,GO:0072162,Lupus Nephritis,MESH:D008181,0,,1,STAT1
metanephric mesenchymal cell proliferation involved in metanephros development,GO:0072136,Lupus Nephritis,MESH:D008181,0,,1,STAT1
metaphase plate congression,GO:0051310,"Lupus Erythematosus, Systemic",MESH:D008180,1,Vincristine,0,
metestrus,GO:0060210,"Lupus Erythematosus, Systemic",MESH:D008180,1,triptolide,0,
methanol biosynthetic process,GO:0046169,"Lupus Erythematosus, Systemic",MESH:D008180,1,Methotrexate,0,
methionine metabolic process,GO:0006555,"Lupus Erythematosus, Systemic",MESH:D008180,2,Homocysteine|Particulate Matter,0,
methotrexate transport,GO:0051958,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Methotrexate,0,
methylation,GO:0032259,"Lupus Erythematosus, Systemic",MESH:D008180,2,Folic Acid|Particulate Matter,1,PRDM1
MHC class II biosynthetic process,GO:0045342,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,IL4
microglia development,GO:0014005,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,1,ITGAM
microglia development,GO:0014005,Lupus Nephritis,MESH:D008181,1,Lipopolysaccharides,0,
microglia development,GO:0014005,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
microglial cell activation,GO:0001774,"Lupus Erythematosus, Systemic",MESH:D008180,2,Minocycline|Particulate Matter,5,C1QA|CLU|IL4|ITGAM|P2RY12
microglial cell activation,GO:0001774,Lupus Nephritis,MESH:D008181,2,Lipopolysaccharides|Rutin,1,IFNG
microglial cell activation,GO:0001774,"Lupus Vasculitis, Central Nervous System",MESH:D020945,0,,1,ITGAM
microglial cell migration,GO:1904124,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
microglial cell proliferation,GO:0061518,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Lupus Erythematosus, Systemic",MESH:D008180,4,Cyclophosphamide|Melatonin|Particulate Matter|Valproic Acid,1,CLU
microglial cell proliferation,GO:0061518,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
microglial cell proliferation,GO:0061518,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
micronucleus organization,GO:0032125,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Fluorouracil|Hydroxychloroquine|Rifampin,0,
micronucleus organization,GO:0032125,"Lupus Erythematosus, Discoid",MESH:D008179,1,Hydroxychloroquine,0,
micronucleus organization,GO:0032125,"Lupus Erythematosus, Systemic",MESH:D008180,10,Carbamazepine|chloroquine diphosphate|Cyclophosphamide|Diclofenac|Estradiol|Folic Acid|Hydroxychloroquine|Particulate Matter|Rifampin|Vincristine,0,
micronucleus organization,GO:0032125,Lupus Nephritis,MESH:D008181,4,Cyclophosphamide|Dexamethasone|Diethylstilbestrol|Rifampin,0,
micronucleus organization,GO:0032125,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
microtubule cytoskeleton organization,GO:0000226,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"Lupus Erythematosus, Systemic",MESH:D008180,3,Particulate Matter|Valproic Acid|Vincristine,0,
microtubule polymerization,GO:0046785,Lupus Nephritis,MESH:D008181,1,Niclosamide,0,
microvillus organization,GO:0032528,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
micturition,GO:0060073,"Lupus Erythematosus, Cutaneous",MESH:D008178,1,Chloroquine,0,
micturition,GO:0060073,"Lupus Erythematosus, Discoid",MESH:D008179,1,Chloroquine,0,
micturition,GO:0060073,"Lupus Erythematosus, Systemic",MESH:D008180,3,Chloroquine|Cyclophosphamide|Methotrexate,0,
micturition,GO:0060073,Lupus Nephritis,MESH:D008181,1,Cyclophosphamide,0,
micturition,GO:0060073,"Lupus Vasculitis, Central Nervous System",MESH:D020945,1,Cyclophosphamide,0,
midbrain development,GO:0030901,"Lupus Erythematosus, Systemic",MESH:D008180,1,Folic Acid,0,
midbrain morphogenesis,GO:1904693,"Lupus Erythematosus, Systemic",MESH:D008180,1,Homocysteine,0,
miRNA transcription,GO:0061614,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
miRNA transport,GO:1990428,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
mismatch repair,GO:0006298,Chilblain lupus 1,MESH:C535924,0,,1,TREX1
mismatch repair,GO:0006298,"Lupus Erythematosus, Systemic",MESH:D008180,0,,1,TREX1
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Lupus Erythematosus, Systemic",MESH:D008180,2,Amiodarone|Diclofenac,0,
mitochondrial calcium ion homeostasis,GO:0051560,"Lupus Erythematosus, Systemic",MESH:D008180,2,Cocaine|Homocysteine,0,
mitochondrial calcium ion transmembrane transport,GO:0006851,"Lupus Erythematosus, Systemic",MESH:D008180,1,Indomethacin,0,
mitochondrial cytochrome c oxidase assembly,GO:0033617,"Lupus Erythematosus, Systemic",MESH:D008180,1,Particulate Matter,0,
mitochondrial depolarization,GO:0051882,"Lupus Erythematosus, Cutaneous",MESH:D008178,3,Chloroquine|Hydroxychloroquine|Rifampin,0,
mitochondrial depolarization,GO:0051882,"Lupus Erythematosus, Discoid",MESH:D008179,2,Chloroquine|Hydroxychloroquine,0,
mitochondrial depolarization,GO:0051882,"Lupus Erythematosus, Systemic",MESH:D008180,7,Aspirin|Chloroquine|chloroquine diphosphate|Hydroxychloroquine|Particulate Matter|Rifampin|triptolide,0,
mitochondrial depolarization,GO:0051882,Lupus Nephritis,MESH:D008181,3,Dexamethasone|Lipopolysaccharides|Rifampin,0,
mitochondrial DNA metabolic process,GO:0032042,"Lupus Erythematosus, Systemic",MESH:D008180,3,Folic Acid|Particulate Matter|Vitamin B 12,0,
mitochondrial DNA replication,GO:0006264,"Lupus Erythematosus, Systemic",MESH:D008180,4,Melatonin|Silicon Dioxide|Tobacco Smoke Pollution|triptolide,0,
mitochondrial DNA replication,GO:0006264,Lupus Nephritis,MESH:D008181,2,Dexamethasone|Lipopolysaccharides,0,
